Library and Knowledge Services - HeLLO of... · Library and Knowledge Services . ... light eruption,20 prurigo simplex subacuta,21 ... Another trial is looking at a tyrosine kinase

1

Library and Knowledge Services

Please find below the results of your literature search request. If you would like the full text of any of the abstracts included, or would like a further search completed on this topic, please let us know. We’d appreciate feedback on your satisfaction with this literature search. Please visit http://www.hello.nhs.uk/literature_search_feedback.asp and complete the form. Thank you

Literature search results

Search completed for:

Search required by: 30 June 2012

Search completed on: 28 June 2012

Search completed by: Richard Bridgen

Search details

Management of mastocytosis. Details of management of cutaneous and systemic forms of the condition.

Resources searched

NHS Evidence; TRIP Database; Cochrane Library; CINAHL; EMBASE; MEDLINE; Google Scholar

Database search terms : mastocyto*; exp MASTOCYTOMA; exp MASTOCYTOSIS; “diffuse mastocytosis”; diffuse adj2 mastocytosis; “diffuse cutaneous mastocytosis”; “systemic mastocytosis”; exp MASTOCYTOSIS, CUTANEOUS; exp MASTOCYTOSIS, SYSTEMIC; leukemia adj2 mast-cell; leukemia adj2 “mast cell”; leulemia adj2 mastcell; leukaemia adj2 mast-cell; leukaemia adj2 “mast cell”; leukaemia adj2 mastcell; urticarial adj2 pigmentosa; mastocytoma adj2 skin; “mast cell” adj2 diffuse “mast cell” adj2 cutaneous; “mast cell” adj2 systemic; therap*; treatment*; intervention*; manage*; exp THERAPEUTICS; exp THERAPY; adult; exp ADULTS; aged; exp AGED; senior*; elder*; “older peope”; “older person*”

NHS Evidence search strings: "diffuse cutaneous mastocytosis" OR "diffuse mastocytosis" OR "systemic mastocytosis" OR "mast-cell leukaemia" OR "mast-cell leukemia" OR "urticaria pigmentosa" OR "mastocytoma of the skin" OR "skin mastocytoma"

(mastocyto* ("diffuse cutaneous" OR diffuse OR systemic)) OR "mast-cell leukaemia" OR "mast-cell leukemia" OR "urticaria pigmentosa" OR "mastocytoma of the skin" OR "skin mastocytoma"

Google search string : (~"diffuse cutaneous mastocytosis" OR ~"diffuse mastocytosis" OR ~"systemic mastocytosis" OR ~"mast-cell leukemia" OR ~"urticartia pigmentosa") (~therapy OR ~treatment OR ~intervention OR ~management)

http://www.hello.nhs.uk/literature_search_feedback.asp

2

Summary

There is a huge amount of research on mastocytosis, even in the specific forms you indicated. I have therefore concentrated on the management of cutaneous and systemic mastocytosis and omitted anything dealing with the treatment of conditions where the patient already has mastocytois, aetiology, incidence, prognosis and diagnosis.

Guidelines

British Association of Dermatologists

Guidelines for Topical PUVA: a report of a workshop of the British Photodermatology Group 2000

There is a paucity of evidence concerning the efficacy of bath PUVA in other dermatoses, although there are reports (Table 1a) of its value in lichen planus,

12-15 systemic sclerosis

and generalized morphoea,16,17

urticaria pigmentosa,13,18

mycosis fungoides,19

polymorphic light eruption,

20 prurigo simplex subacuta,21 nodular prurigo,

12,22 aquagenic pruritus,

23,24

and lymphomatoid papulosis.25

In the absence of controlled studies to examine the efficacy of bath PUVA in generalized disorders other than chronic plaque psoriasis, we suggest that a common sense approach is to try a course of bath PUVA in the above conditions if other measu

Evidence-based reviews

CancerHelp UK

Acute myeloid leukaemia research 2012

Another trial is looking at a tyrosine kinase inhibitor drug called midostaurin (also known as PKC412) for people who have mast cell leukaemia (a very rare type of AML). The trial aims to find out if midostaurin helps people with mast cell leukaemia and to learn about how it works and its side effects.

Clinical Immediate Reference

Mastocytosis and Mast Cell Disorders 2011

New Drugs Online

Midostaurin

Published research

1. Complete response after imatinib mesylate therapy in a patient with well-differentiated systemic mastocytosis.

Author(s) Alvarez-Twose I, Gonzalez P, Morgado JM, Jara-Acevedo M, Sanchez-Munoz L, Matito A, Mollejo M, Orfao A, Escribano L

Citation: Journal of Clinical Oncology, April 2012, vol./is. 30/12(e126-9), 0732-183X;1527-7755 (2012 Apr 20)

Publication Date: April 2012

Source: Medline

Available in fulltext at the ULHT Library and Knowledge Services' eJournal collection

2. Systemic mastocytosis in adults: 2012 Update on diagnosis, risk stratification, and management.

Author(s) Pardanani A

http://www.bad.org.uk/Portals/_Bad/Guidelines/Clinical%20Guidelines/Topical%20PUVA%20Therapy.pdf

http://cancerhelp.cancerresearchuk.org/type/aml/treatment/whats-new-in-acute-myeloid-leukaemia-research

http://www.patient.co.uk/doctor/Mastocytosis-and-Mast-Cell-Disorders.htm

http://www.ukmi.nhs.uk/applications/ndo/record_view_open.asp?newDrugID=5023

http://www.library.nhs.uk/hdas/resultdetail?ShowAbstracts=False&Database=bnj.ovi.prmz&Id=ovid.com%3A%2Fbib%2Fmedline%2F22370312&Search=1000000&PageNumber=1&PageSize=50&Index=1&SortBy=srt.date&SimpleSearch=False&Clipboard=True&databases=bnj.ovi.prmz


http://nhs4315978.resolver.library.nhs.uk/linker?linkScheme=highwire&linktype=best&genre=article&volume=30&issue=12&epage=9&issn=0732-183X&eissn=1527-7755&date=2012-04&pages=e126-9&aulast=Alvarez-Twose&auinit=I&title=Journal+of+Clinical+Oncology&atitle=Complete+response+after+imatinib+mesylate+therapy+in+a+patient+with+well-differentiated+systemic+mastocytosis.&sid=Elsevier%3AScienceDirect&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&jHome=http%3A%2F%2Fwww.jco.org%2Fathens&provider=customer&pkgName=nhs43159782



3

Citation: American Journal of Hematology, April 2012, vol./is. 87/4(401-11), 0361-8609;1096-8652 (2012 Apr)


Source: Medline

Available in print at ULHT journal article requests. Complete the online form to obtain articles.

3. Indolent systemic mastocytosis treated with narrow-band UVB phototherapy: Study of five cases

Author(s) Brazzelli V., Grasso V., Manna G., Barbaccia V., Merante S., Boveri E., Borroni G.

Citation: Journal of the European Academy of Dermatology and Venereology, April 2012, vol./is. 26/4(465-469), 0926-9959;1468-3083 (April 2012)


Source: EMBASE


4. Urticaria pigmentosa after treatment with TNF antagonists: A case report

Author(s) Leloup P., Daviet V., Chiffoleau A., Dreno B.

Citation: Archives of Dermatology, December 2011, vol./is. 147/12(1459-1460), 0003-987X;1538-3652 (December 2011)

Publication Date: December 2011

Source: EMBASE

Available in fulltext at Highwire Press


5. Urticaria pigmentosa after treatment with TNF antagonists: a case report.

Author(s) Leloup P, Daviet V, Chiffoleau A, Dreno B

Citation: Archives of Dermatology, December 2011, vol./is. 147/12(1459-60), 0003-987X;1538-3652 (2011 Dec)


Source: Medline



6. Novel, activating KIT-N822I mutation in familial cutaneous mastocytosis.

Author(s) Wasag B, Niedoszytko M, Piskorz A, Lange M, Renke J, Jassem E, Biernat W, Debiec-Rychter M, Limon J

Citation: Experimental Hematology, August 2011, vol./is. 39/8(859-65.e2), 0301-472X;1873-2399 (2011 Aug)

Publication Date: August 2011

Source: Medline

Available in print at ULHT journal article requests. Complete the online form to obtain

http://nhs4315978.resolver.library.nhs.uk/linker?template=slinks:redirect&linkclass=hlisd&issn=0361-8609&title=American+journal+of+hematology&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&provider=customer&pkgName=nhs43159782&jHome=http%3A%2F%2Fwww.hello.nhs.uk%2Fjournal_articles.asp


http://www.library.nhs.uk/hdas/resultdetail?ShowAbstracts=False&Database=bnj.ovi.emez&Id=ovid.com%3A%2Fbib%2Fembase%2F2012175181&Search=1000000&PageNumber=1&PageSize=50&Index=3&SortBy=srt.date&SimpleSearch=False&Clipboard=True&databases=bnj.ovi.prmz


http://nhs4315978.resolver.library.nhs.uk/linker?template=slinks:redirect&linkclass=hlisd&issn=0926-9959&title=Journal+of+the+European+Academy+of+Dermatology+and+Venereology+%3A+JEADV&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&provider=customer&pkgName=nhs43159782&jHome=http%3A%2F%2Fwww.hello.nhs.uk%2Fjournal_articles.asp

http://nhs4315978.resolver.library.nhs.uk/linker?template=slinks:redirect&linkclass=hlisd&issn=0926-9959&title=Journal+of+the+European+Academy+of+Dermatology+and+Venereology+%3A+JEADV&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&provider=customer&pkgName=nhs43159782&jHome=http%3A%2F%2Fwww.hello.nhs.uk%2Fjournal_articles.asp


http://nhs4315978.resolver.library.nhs.uk/linker?template=slinks:highwire.stanford.edu/articleAthens&jKey=archderm.ama-assn.org&genre=article&volume=147&issue=12&epage=1460&issn=0003-987X&date=2011-12&pages=1459-1460&aulast=Leloup+P&auinit=.&title=Archives+of+Dermatology&atitle=Urticaria+pigmentosa+after+treatment+with+TNF+antagonists%3A+A+case+report&sid=Elsevier%3AScienceDirect&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&jHome=http%3A%2F%2Farchderm.ama-assn.org&dbKey=none%22)&provider=highwire&pkgName=amassoc

http://nhs4315978.resolver.library.nhs.uk/linker?template=slinks:redirect&linkclass=hlisd&issn=0003-987X&title=Archives+of+Dermatology&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&provider=customer&pkgName=nhs43159782&jHome=http%3A%2F%2Fwww.hello.nhs.uk%2Fjournal_articles.asp



http://nhs4315978.resolver.library.nhs.uk/linker?template=slinks:highwire.stanford.edu/articleAthens&jKey=archderm.ama-assn.org&genre=article&volume=147&issue=12&epage=60&issn=0003-987X&date=2011-12&pages=1459-60&aulast=Leloup&auinit=P&title=Archives+of+Dermatology&atitle=Urticaria+pigmentosa+after+treatment+with+TNF+antagonists%3A+a+case+report.&sid=Elsevier%3AScienceDirect&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&jHome=http%3A%2F%2Farchderm.ama-assn.org&dbKey=none%22)&provider=highwire&pkgName=amassoc




http://nhs4315978.resolver.library.nhs.uk/linker?template=slinks:redirect&linkclass=hlisd&issn=0301-472X&title=Experimental+hematology&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&provider=customer&pkgName=nhs43159782&jHome=http%3A%2F%2Fwww.hello.nhs.uk%2Fjournal_articles.asp

4

articles.

7. Interferon alpha and pamidronate in osteoporosis with fracture secondary to mastocytosis.

Author(s) Laroche M, Livideanu C, Paul C, Cantagrel A

Citation: American Journal of Medicine, August 2011, vol./is. 124/8(776-8), 0002-9343;1555-7162 (2011 Aug)


Source: Medline


8. Imatinib mesylate for aggressive systemic mastocytosis with long bone osteolysis.

Author(s) Jung AG, Horny HP, Sotlar K, Overbeck T, Schon MP, Lippert U

Citation: Journal of the American Academy of Dermatology, July 2011, vol./is. 65/1(224-6), 0190-9622;1097-6787 (2011 Jul)

Publication Date: July 2011

Source: Medline


9. A case of mast cell leukaemia with exon 9 KIT mutation and good response to imatinib.

Author(s) Mital A, Piskorz A, Lewandowski K, Wasag B, Limon J, Hellmann A

Citation: European Journal of Haematology, June 2011, vol./is. 86/6(531-5), 0902-4441;1600-0609 (2011 Jun)

Publication Date: June 2011

Source: Medline

Available in fulltext at EBSCOhost


10. Response to cladribine in patient with systemic mastocytosis.

Author(s) Radojkovic M, Ristic S, Colovic N, Terzic T, Colovic M

Citation: Vojnosanitetski Pregled, May 2011, vol./is. 68/5(444-6), 0042-8450;0042-8450 (2011 May)

Publication Date: May 2011

Source: Medline



11. Response to cladribine in patient with systemic mastocytosis [English;Bosnian] Primena kladribina u lecenju bolesnika sa sistemskom mastocitozom

Author(s) Radojkovic M., Ristic S., Colovic N., Terzic T., Colovic M.




http://nhs4315978.resolver.library.nhs.uk/linker?template=slinks:redirect&linkclass=hlisd&issn=0002-9343&title=American+Journal+of+Medicine&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&provider=customer&pkgName=nhs43159782&jHome=http%3A%2F%2Fwww.hello.nhs.uk%2Fjournal_articles.asp

http://nhs4315978.resolver.library.nhs.uk/linker?template=slinks:redirect&linkclass=hlisd&issn=0002-9343&title=American+Journal+of+Medicine&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&provider=customer&pkgName=nhs43159782&jHome=http%3A%2F%2Fwww.hello.nhs.uk%2Fjournal_articles.asp



http://nhs4315978.resolver.library.nhs.uk/linker?linkScheme=harcourt&linktype=best&genre=article&volume=65&issue=1&epage=6&issn=0190-9622&date=2011-07&pages=224-6&aulast=Jung&auinit=AG&title=Journal+of+the+American+Academy+of+Dermatology&atitle=Imatinib+mesylate+for+aggressive+systemic+mastocytosis+with+long+bone+osteolysis.&sid=Elsevier%3AScienceDirect&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&jHome=http%3A%2F%2Fgateway.ovid.com%2Fathens%2Fovidweb.cgi%3FT%3DJS%26MODE%3Dovid%26NEWS%3Dn%26PAGE%3Dtoc%26D%3Dovft%26AN%3D00004725-000000000-00000&provider=customer&pkgName=nhs43159782



http://nhs4315978.resolver.library.nhs.uk/linker?linkScheme=ebscoh&linktype=best&jKey=8DW&dbKey=owh&genre=article&volume=86&issue=6&epage=5&issn=0902-4441&date=2011-06&pages=531-5&aulast=Mital&auinit=A&title=European+Journal+of+Haematology&atitle=A+case+of+mast+cell+leukaemia+with+exon+9+KIT+mutation+and+good+response+to+imatinib.&sid=Elsevier%3AScienceDirect&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&jHome=http%3A%2F%2Fsearch.ebscohost.com%2Fdirect.asp%3Fdb%3Dmnh%26jid%3D8DW%26scope%3Dsite&dbKey=owh&provider=EBSCOhost&pkgName=owh

http://nhs4315978.resolver.library.nhs.uk/linker?template=slinks:redirect&linkclass=hlisd&issn=0902-4441&title=European+journal+of+haematology&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&provider=customer&pkgName=nhs43159782&jHome=http%3A%2F%2Fwww.hello.nhs.uk%2Fjournal_articles.asp



http://nhs4315978.resolver.library.nhs.uk/linker?linkScheme=ebscoh&linktype=best&jKey=VV6&dbKey=owh&genre=article&volume=68&issue=5&epage=6&issn=0042-8450&date=2011-05&pages=444-6&aulast=Radojkovic&auinit=M&title=Vojnosanitetski+Pregled%3A+Military+Medical+and+Pharmaceutical+Journal+of+Serbia+and+Montenegro&atitle=Response+to+cladribine+in+patient+with+systemic+mastocytosis.&sid=Elsevier%3AScienceDirect&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&jHome=http%3A%2F%2Fsearch.ebscohost.com%2Fdirect.asp%3Fdb%3Dmnh%26jid%3DVV6%26scope%3Dsite&dbKey=owh&provider=EBSCOhost&pkgName=owh

http://nhs4315978.resolver.library.nhs.uk/linker?template=slinks:redirect&linkclass=hlisd&issn=0042-8450&title=Vojnosanitetski+pregled.+Military-medical+and+pharmaceutical+review&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&provider=customer&pkgName=nhs43159782&jHome=http%3A%2F%2Fwww.hello.nhs.uk%2Fjournal_articles.asp




5

Citation: Vojnosanitetski Pregled, May 2011, vol./is. 68/5(444-446), 0042-8450 (May 2011)


Source: EMBASE



12. A global phase II, single-arm, open-label study to determine the efficacy of midostaurin in patients with aggressive systemic mastocytosis (ASM) or mast cell leukemia (MCL) with or without an associated hematologic clonal nonmast cell lineage disease (AHNMD)

Author(s) Gotlib J.R., Kluin-Nelemans H., Mauro M.J., Hermine O., Hexner E.O., Lipton J.H., Awan F.T., Nikolova Z.G., Gross S.H., Dutreix C., Dharan B., George T., Horny P., Akin C., Hartmann K., Valent P., Reiter A.

Citation: Journal of Clinical Oncology, May 2011, vol./is. 29/15 SUPPL. 1, 0732-183X (20 May 2011)


Source: EMBASE


13. Systemic mastocytosis in adults: 2011 update on diagnosis, risk stratification, and management.

Author(s) Pardanani A

Citation: American Journal of Hematology, April 2011, vol./is. 86/4(362-71), 0361-8609;1096-8652 (2011 Apr)


Source: Medline


14. Clinical impact of pregnancy in mastocytosis: a study of the Spanish Network on Mastocytosis (REMA) in 45 cases.

Author(s) Matito A, Alvarez-Twose I, Morgado JM, Sanchez-Munoz L, Orfao A, Escribano L

Citation: International Archives of Allergy & Immunology, 2011, vol./is. 156/1(104-11), 1018-2438;1423-0097 (2011)

Publication Date: 2011

Source: Medline



15. Unpredicted adverse reaction to omalizumab.

Author(s) Jandus P, Hausmann O, Haeberli G, Gentinetta T, Mueller U, Helbling A

Citation: Journal of Investigational Allergology & Clinical Immunology, 2011, vol./is. 21/7(563-6), 1018-9068;1018-9068 (2011)


http://nhs4315978.resolver.library.nhs.uk/linker?linkScheme=ebscoh&linktype=best&jKey=VV6&dbKey=owh&genre=article&volume=68&issue=5&epage=446&issn=0042-8450&date=2011-05&pages=444-446&aulast=Radojkovic+M&auinit=.&title=Vojnosanitetski+Pregled%3A+Military+Medical+and+Pharmaceutical+Journal+of+Serbia+and+Montenegro&atitle=Response+to+cladribine+in+patient+with+systemic+mastocytosis+%5BEnglish%3BBosnian%5D+Primena+kladribina+u+lecenju+bolesnika+sa+sistemskom+mastocitozom&sid=Elsevier%3AScienceDirect&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&jHome=http%3A%2F%2Fsearch.ebscohost.com%2Fdirect.asp%3Fdb%3Dmnh%26jid%3DVV6%26scope%3Dsite&dbKey=owh&provider=EBSCOhost&pkgName=owh







http://nhs4315978.resolver.library.nhs.uk/linker?linkScheme=highwire&linktype=best&genre=article&volume=29&issue=15+SUPPL.+1&issn=0732-183X&eissn=1527-7755&date=2011-05&aulast=Gotlib+J.R&auinit=.&title=Journal+of+Clinical+Oncology&atitle=A+global+phase+II%2C+single-arm%2C+open-label+study+to+determine+the+efficacy+of+midostaurin+in+patients+with+aggressive+systemic+mastocytosis+%28ASM%29+or+mast+cell+leukemia+%28MCL%29+with+or+without+an+associated+hematologic+clonal+nonmast+cell+lineage+disease+%28AHNMD%29&sid=Elsevier%3AScienceDirect&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&jHome=http%3A%2F%2Fwww.jco.org%2Fathens&provider=customer&pkgName=nhs43159782







http://nhs4315978.resolver.library.nhs.uk/linker?linkScheme=ebscoh&linktype=best&jKey=1GX&dbKey=owh&genre=article&volume=156&issue=1&epage=11&issn=1018-2438&date=2011&pages=104-11&aulast=Matito&auinit=A&title=International+Archives+of+Allergy+and+Immunology&atitle=Clinical+impact+of+pregnancy+in+mastocytosis%3A+a+study+of+the+Spanish+Network+on+Mastocytosis+%28REMA%29+in+45+cases.&sid=Elsevier%3AScienceDirect&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&jHome=http%3A%2F%2Fsearch.ebscohost.com%2Fdirect.asp%3Fdb%3Dmnh%26jid%3D1GX%26scope%3Dsite&dbKey=owh&provider=EBSCOhost&pkgName=owh

http://nhs4315978.resolver.library.nhs.uk/linker?template=slinks:redirect&linkclass=hlisd&issn=1018-2438&title=International+archives+of+allergy+and+immunology&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&provider=customer&pkgName=nhs43159782&jHome=http%3A%2F%2Fwww.hello.nhs.uk%2Fjournal_articles.asp



6

Source: Medline


16. Omalizumab treatment of systemic mast cell activation disease: experiences from four cases.

Author(s) Molderings GJ, Raithel M, Kratz F, Azemar M, Haenisch B, Harzer S, Homann J

Citation: Internal Medicine, 2011, vol./is. 50/6(611-5), 0918-2918;1349-7235 (2011)


Source: Medline


17. Masitinib for the treatment of systemic and cutaneous mastocytosis with handicap: A phase 2a study

Author(s) Paul C., Sans B., Suarez F., Casassus P., Barete S., Lanternier F., Grandpeix-Guyodo C., Dubreuil P., Palmerini F., Mansfield C.D., Gineste P., Moussy A., Hermine O., Lortholary O.

Citation: American Journal of Hematology, December 2010, vol./is. 85/12(921-925), 0361-8609;1096-8652 (December 2010)


Source: EMBASE


18. Cutaneous mastocytosis: Successful treatment with narrowband ultraviolet B phototherapy

Author(s) Prignano F., Troiano M., Lotti T.

Citation: Clinical and Experimental Dermatology, December 2010, vol./is. 35/8(914-915), 0307-6938;1365-2230 (December 2010)


Source: EMBASE



19. Long term efficacy and safety of cladribine in adult systemic mastocytosis: A French multicenter study of 44 patients

Author(s) Hermine O., Hirsh I., Damaj G., Granpeix C., Barete S., Suarez F., Chansderis O., Ghez D., Delarue R., Lanternier F., Deau B., Coignard H., Fraitag S., Canioni D., Casassus P., Dubreuil P., Lortholary O.

Citation: Blood, November 2010, vol./is. 116/21, 0006-4971 (19 Nov 2010)

Publication Date: November 2010

Source: EMBASE



http://nhs4315978.resolver.library.nhs.uk/linker?template=slinks:redirect&linkclass=hlisd&issn=1018-9068&title=Journal+of+investigational+allergology+%26+clinical+immunology+%3A+official+organ+of+the+International+Association+of+Asthmology+%28INTERASMA%29+and+Sociedad+Latinoamericana+de+Alergia+e+Inmunologia&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&provider=customer&pkgName=nhs43159782&jHome=http%3A%2F%2Fwww.hello.nhs.uk%2Fjournal_articles.asp

http://nhs4315978.resolver.library.nhs.uk/linker?template=slinks:redirect&linkclass=hlisd&issn=1018-9068&title=Journal+of+investigational+allergology+%26+clinical+immunology+%3A+official+organ+of+the+International+Association+of+Asthmology+%28INTERASMA%29+and+Sociedad+Latinoamericana+de+Alergia+e+Inmunologia&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&provider=customer&pkgName=nhs43159782&jHome=http%3A%2F%2Fwww.hello.nhs.uk%2Fjournal_articles.asp



http://nhs4315978.resolver.library.nhs.uk/linker?template=slinks:redirect&linkclass=hlisd&issn=0918-2918&title=Internal+medicine+%28Tokyo%2C+Japan%29&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&provider=customer&pkgName=nhs43159782&jHome=http%3A%2F%2Fwww.hello.nhs.uk%2Fjournal_articles.asp








http://nhs4315978.resolver.library.nhs.uk/linker?linkScheme=ebscoh&linktype=best&jKey=DF2&dbKey=owh&genre=article&volume=35&issue=8&epage=915&issn=0307-6938&date=2010-12&pages=914-915&aulast=Prignano+F&auinit=.&title=Clinical+and+Experimental+Dermatology&atitle=Cutaneous+mastocytosis%3A+Successful+treatment+with+narrowband+ultraviolet+B+phototherapy&sid=Elsevier%3AScienceDirect&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&jHome=http%3A%2F%2Fsearch.ebscohost.com%2Fdirect.asp%3Fdb%3Dmnh%26jid%3DDF2%26scope%3Dsite&dbKey=owh&provider=EBSCOhost&pkgName=owh

http://nhs4315978.resolver.library.nhs.uk/linker?template=slinks:redirect&linkclass=hlisd&issn=0307-6938&title=Clinical+and+experimental+dermatology&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&provider=customer&pkgName=nhs43159782&jHome=http%3A%2F%2Fwww.hello.nhs.uk%2Fjournal_articles.asp




http://nhs4315978.resolver.library.nhs.uk/linker?linkScheme=highwire2&linktype=best&jKey=bloodjournal.hematologylibrary.org&genre=article&volume=116&issue=21&issn=0006-4971&eissn=1528-0020&date=2010-11&aulast=Hermine+O&auinit=.&title=Blood&atitle=Long+term+efficacy+and+safety+of+cladribine+in+adult+systemic+mastocytosis%3A+A+French+multicenter+study+of+44+patients&sid=Elsevier%3AScienceDirect&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&jHome=http%3A%2F%2Fbloodjournal.hematologylibrary.org&provider=highwire&pkgName=freeart

http://nhs4315978.resolver.library.nhs.uk/linker?template=slinks:redirect&linkclass=hlisd&issn=0006-4971&title=Blood&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&provider=customer&pkgName=nhs43159782&jHome=http%3A%2F%2Fwww.hello.nhs.uk%2Fjournal_articles.asp


7

20. Systemic Mastocytosis and surgery a potential disaster.

Author(s) Yunaev M, Hughes TM, Abdul-Razak M

Citation: ANZ Journal of Surgery, November 2010, vol./is. 80/11(860-1), 1445-1433;1445-2197 (2010 Nov)


Source: Medline



21. Use of oral ketamine in a patient with systemic mastocytosis.

Author(s) Yoong J, Le B

Citation: Internal Medicine Journal, October 2010, vol./is. 40/10(735-6), 1444-0903;1445-5994 (2010 Oct)

Publication Date: October 2010

Source: Medline



22. In vitro and in vivo growth-inhibitory effects of cladribine on neoplastic mast cells exhibiting the imatinib-resistant KIT mutation D816V.

Author(s) Bohm A, Sonneck K, Gleixner KV, Schuch K, Pickl WF, Blatt K, Peter B, Herrmann H, Schernthaner GH, Pehamberger H, Rabitsch W, Sperr WR, Valent P

Citation: Experimental Hematology, September 2010, vol./is. 38/9(744-55), 0301-472X;1873-2399 (2010 Sep)

Publication Date: September 2010

Source: Medline


23. Omalizumab is effective in treating systemic mastocytosis in a nonatopic patient

Author(s) Douglass J.A., Carroll K., Voskamp A., Bourke P., Wei A., O'Hehir R.E.

Citation: Allergy: European Journal of Allergy and Clinical Immunology, July 2010, vol./is. 65/7(926-927), 0105-4538;1398-9995 (July 2010)


Source: EMBASE



24. Treatment of aggressive systemic mastocytosis with daclizumab.

Author(s) Quintas-Cardama A, Amin HM, Kantarjian H, Verstovsek S

Citation: Leukemia & Lymphoma, March 2010, vol./is. 51/3(540-2), 1026-8022;1029-2403


http://nhs4315978.resolver.library.nhs.uk/linker?linkScheme=ebscoh&linktype=best&jKey=HWR&dbKey=owh&genre=article&volume=80&issue=11&epage=1&issn=1445-1433&date=2010-11&pages=860-1&aulast=Yunaev&auinit=M&title=ANZ+Journal+of+Surgery&atitle=Systemic+Mastocytosis+and+surgery+a+potential+disaster.&sid=Elsevier%3AScienceDirect&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&jHome=http%3A%2F%2Fsearch.ebscohost.com%2Fdirect.asp%3Fdb%3Dmnh%26jid%3DHWR%26scope%3Dsite&dbKey=owh&provider=EBSCOhost&pkgName=owh

http://nhs4315978.resolver.library.nhs.uk/linker?template=slinks:redirect&linkclass=hlisd&issn=1445-1433&title=ANZ+journal+of+surgery&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&provider=customer&pkgName=nhs43159782&jHome=http%3A%2F%2Fwww.hello.nhs.uk%2Fjournal_articles.asp

http://nhs4315978.resolver.library.nhs.uk/linker?template=slinks:redirect&linkclass=hlisd&issn=1445-1433&title=ANZ+journal+of+surgery&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&provider=customer&pkgName=nhs43159782&jHome=http%3A%2F%2Fwww.hello.nhs.uk%2Fjournal_articles.asp


http://nhs4315978.resolver.library.nhs.uk/linker?linkScheme=ebscoh&linktype=best&jKey=HYC&dbKey=owh&genre=article&volume=40&issue=10&epage=6&issn=1444-0903&date=2010-10&pages=735-6&aulast=Yoong&auinit=J&title=Internal+Medicine+Journal&atitle=Use+of+oral+ketamine+in+a+patient+with+systemic+mastocytosis.&sid=Elsevier%3AScienceDirect&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&jHome=http%3A%2F%2Fsearch.ebscohost.com%2Fdirect.asp%3Fdb%3Dmnh%26jid%3DHYC%26scope%3Dsite&dbKey=owh&provider=EBSCOhost&pkgName=owh

http://nhs4315978.resolver.library.nhs.uk/linker?template=slinks:redirect&linkclass=hlisd&issn=1444-0903&title=Internal+medicine+journal&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&provider=customer&pkgName=nhs43159782&jHome=http%3A%2F%2Fwww.hello.nhs.uk%2Fjournal_articles.asp

http://nhs4315978.resolver.library.nhs.uk/linker?template=slinks:redirect&linkclass=hlisd&issn=1444-0903&title=Internal+medicine+journal&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&provider=customer&pkgName=nhs43159782&jHome=http%3A%2F%2Fwww.hello.nhs.uk%2Fjournal_articles.asp






http://nhs4315978.resolver.library.nhs.uk/linker?linkScheme=ebscoh&linktype=best&jKey=1X5&dbKey=owh&genre=article&volume=65&issue=7&epage=927&issn=0105-4538&date=2010-07&pages=926-927&aulast=Douglass+J.A&auinit=.&title=Allergy&atitle=Omalizumab+is+effective+in+treating+systemic+mastocytosis+in+a+nonatopic+patient&sid=Elsevier%3AScienceDirect&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&jHome=http%3A%2F%2Fsearch.ebscohost.com%2Fdirect.asp%3Fdb%3Dmnh%26jid%3D1X5%26scope%3Dsite&dbKey=owh&provider=EBSCOhost&pkgName=owh

http://nhs4315978.resolver.library.nhs.uk/linker?template=slinks:redirect&linkclass=hlisd&issn=0105-4538&title=Allergy&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&provider=customer&pkgName=nhs43159782&jHome=http%3A%2F%2Fwww.hello.nhs.uk%2Fjournal_articles.asp



8

(2010 Mar)

Publication Date: March 2010

Source: Medline



25. Systemic mastocytosis in adults: a review on prognosis and treatment based on 342 Mayo Clinic patients and current literature.

Author(s) Pardanani A, Tefferi A

Citation: Current Opinion in Hematology, 01 March 2010, vol./is. 17/2(125-132), 10656251

Publication Date: 01 March 2010

Source: CINAHL


26. Experience with everolimus (RAD001), an oral mammalian target of rapamycin inhibitor, in patients with systemic mastocytosis.

Author(s) Parikh SA, Kantarjian HM, Richie MA, Cortes JE, Verstovsek S

Citation: Leukemia & Lymphoma, February 2010, vol./is. 51/2(269-74), 1026-8022;1029-2403 (2010 Feb)

Publication Date: February 2010

Source: Medline



27. Oral and inhaled sodium cromoglicate in the management of systemic mastocytosis: A case report

Author(s) Edwards A.M., Hagberg H.

Citation: Journal of Medical Case Reports, 2010, vol./is. 4/, 1752-1947;1752-1947 (2010)


Source: EMBASE

Available in fulltext at BioMedCentral

Available in fulltext at National Library of Medicine


28. Systemic mastocytosis associated with the c-KIT D816V mutation-importance of molecular diagnosis and therapeutic implications. case report

Author(s) Trifa A.P., Patiu M., Cucuianu A., Dima D., Militaru M.S., Pop I.V., Popp R.A.

Citation: Timisoara Medical Journal, 2010, vol./is. 60/2-3(241-243), 1583-5251;1583-526X (2010)


Source: EMBASE

http://nhs4315978.resolver.library.nhs.uk/linker?linkScheme=ebscoh&linktype=best&jKey=BJL&dbKey=owh&genre=article&volume=51&issue=3&epage=2&issn=1042-8194&date=2010-03&pages=540-2&aulast=Quintas-Cardama&auinit=A&title=Leukemia+and+Lymphoma&atitle=Treatment+of+aggressive+systemic+mastocytosis+with+daclizumab.&sid=Elsevier%3AScienceDirect&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&jHome=http%3A%2F%2Fsearch.ebscohost.com%2Fdirect.asp%3Fdb%3Dmnh%26jid%3DBJL%26scope%3Dsite&dbKey=owh&provider=EBSCOhost&pkgName=owh

http://nhs4315978.resolver.library.nhs.uk/linker?template=slinks:redirect&linkclass=hlisd&issn=1042-8194&title=Leukemia+%26+lymphoma&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&provider=customer&pkgName=nhs43159782&jHome=http%3A%2F%2Fwww.hello.nhs.uk%2Fjournal_articles.asp


http://www.library.nhs.uk/hdas/resultdetail?ShowAbstracts=False&Database=bnj.ebs.cinahl&Id=2010573450&Search=1000000&PageNumber=1&PageSize=50&Index=25&SortBy=srt.date&SimpleSearch=False&Clipboard=True&databases=bnj.ovi.prmz


http://nhs4315978.resolver.library.nhs.uk/linker?template=slinks:redirect&linkclass=hlisd&issn=1065-6251&title=Current+opinion+in+hematology&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&provider=customer&pkgName=nhs43159782&jHome=http%3A%2F%2Fwww.hello.nhs.uk%2Fjournal_articles.asp




http://nhs4315978.resolver.library.nhs.uk/linker?linkScheme=ebscoh&linktype=best&jKey=BJL&dbKey=owh&genre=article&volume=51&issue=2&epage=74&issn=1042-8194&date=2010-02&pages=269-74&aulast=Parikh&auinit=SA&title=Leukemia+and+Lymphoma&atitle=Experience+with+everolimus+%28RAD001%29%2C+an+oral+mammalian+target+of+rapamycin+inhibitor%2C+in+patients+with+systemic+mastocytosis.&sid=Elsevier%3AScienceDirect&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&jHome=http%3A%2F%2Fsearch.ebscohost.com%2Fdirect.asp%3Fdb%3Dmnh%26jid%3DBJL%26scope%3Dsite&dbKey=owh&provider=EBSCOhost&pkgName=owh





http://nhs4315978.resolver.library.nhs.uk/linker?linkScheme=bmc&linktype=best&genre=article&volume=4&issn=1752-1947&date=2010&aulast=Edwards+A.M&auinit=.&title=Journal+of+Medical+Case+Reports&atitle=Oral+and+inhaled+sodium+cromoglicate+in+the+management+of+systemic+mastocytosis%3A+A+case+report&sid=Elsevier%3AScienceDirect&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&jHome=http%3A%2F%2Fwww.jmedicalcasereports.com&provider=BMC&pkgName=openAccess

http://nhs4315978.resolver.library.nhs.uk/linker?linkScheme=pubmed&linktype=best&jKey=966&genre=article&volume=4&issn=1752-1947&eissn=1752-1947&date=2010&aulast=Edwards+A.M&auinit=.&title=Journal+of+Medical+Case+Reports&atitle=Oral+and+inhaled+sodium+cromoglicate+in+the+management+of+systemic+mastocytosis%3A+A+case+report&sid=Elsevier%3AScienceDirect&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&jHome=http%3A%2F%2Fukpmc.ac.uk%2Fjournals%2F966&provider=NLM&pkgName=UKPMCFT

http://nhs4315978.resolver.library.nhs.uk/linker?template=slinks:redirect&linkclass=hlisd&issn=1752-1947&title=Journal+of+Medical+Case+Reports&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&provider=customer&pkgName=nhs43159782&jHome=http%3A%2F%2Fwww.hello.nhs.uk%2Fjournal_articles.asp

http://nhs4315978.resolver.library.nhs.uk/linker?template=slinks:redirect&linkclass=hlisd&issn=1752-1947&title=Journal+of+Medical+Case+Reports&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&provider=customer&pkgName=nhs43159782&jHome=http%3A%2F%2Fwww.hello.nhs.uk%2Fjournal_articles.asp



9


29. Current approaches to the diagnosis and treatment of systemic mastocytosis.

Author(s) Bains SN, Hsieh FH

Citation: Annals of Allergy, Asthma & Immunology, 01 January 2010, vol./is. 104/1(1-), 10811206

Publication Date: 01 January 2010

Source: CINAHL


30. Cutaneous mastocytosis: Successful treatment with nb-uvb phototherapy

Author(s) Troiano M., Lotti T., Prignano F.

Citation: Experimental Dermatology, December 2009, vol./is. 18/12(1095), 0906-6705 (December 2009)


Source: EMBASE



31. Cytoreductive therapy in 108 adults with systemic mastocytosis: Outcome analysis and response prediction during treatment with interferon-alpha, hydroxyurea, imatinib mesylate or 2-chlorodeoxyadenosine.

Author(s) Lim KH, Pardanani A, Butterfield JH, Li CY, Tefferi A

Citation: American Journal of Hematology, December 2009, vol./is. 84/12(790-4), 0361-8609;1096-8652 (2009 Dec)


Source: Medline


32. Phase II study of imatinib mesylate as therapy for patients with systemic mastocytosis.

Author(s) Vega-Ruiz A, Cortes JE, Sever M, Manshouri T, Quintas-Cardama A, Luthra R, Kantarjian HM, Verstovsek S

Citation: Leukemia Research, November 2009, vol./is. 33/11(1481-4), 0145-2126;1873-5835 (2009 Nov)


Source: Medline


33. Multimodal therapy for vertebral involvement of systemic mastocytosis.

Author(s) Krüger A, Hamann C, Brendel C, Ramaswamy A, Schnabel M, Neubauer A,

http://nhs4315978.resolver.library.nhs.uk/linker?template=slinks:redirect&linkclass=hlisd&issn=1583-5251&title=Timisoara+Medical+Journal&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&provider=customer&pkgName=nhs43159782&jHome=http%3A%2F%2Fwww.hello.nhs.uk%2Fjournal_articles.asp

http://nhs4315978.resolver.library.nhs.uk/linker?template=slinks:redirect&linkclass=hlisd&issn=1583-5251&title=Timisoara+Medical+Journal&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&provider=customer&pkgName=nhs43159782&jHome=http%3A%2F%2Fwww.hello.nhs.uk%2Fjournal_articles.asp


http://nhs4315978.resolver.library.nhs.uk/linker?template=slinks:redirect&linkclass=hlisd&issn=1081-1206&title=Annals+of+allergy%2C+asthma+%26+immunology+%3A+official+publication+of+the+American+College+of+Allergy%2C+Asthma%2C+%26+Immunology&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&provider=customer&pkgName=nhs43159782&jHome=http%3A%2F%2Fwww.hello.nhs.uk%2Fjournal_articles.asp

http://nhs4315978.resolver.library.nhs.uk/linker?template=slinks:redirect&linkclass=hlisd&issn=1081-1206&title=Annals+of+allergy%2C+asthma+%26+immunology+%3A+official+publication+of+the+American+College+of+Allergy%2C+Asthma%2C+%26+Immunology&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&provider=customer&pkgName=nhs43159782&jHome=http%3A%2F%2Fwww.hello.nhs.uk%2Fjournal_articles.asp


http://nhs4315978.resolver.library.nhs.uk/linker?linkScheme=ebscoh&linktype=best&jKey=FR9&dbKey=owh&genre=article&volume=18&issue=12&spage=1095&issn=0906-6705&date=2009-12&aulast=Troiano+M&auinit=.&title=Experimental+Dermatology&atitle=Cutaneous+mastocytosis%3A+Successful+treatment+with+nb-uvb+phototherapy&sid=Elsevier%3AScienceDirect&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&jHome=http%3A%2F%2Fsearch.ebscohost.com%2Fdirect.asp%3Fdb%3Dmnh%26jid%3DFR9%26scope%3Dsite&dbKey=owh&provider=EBSCOhost&pkgName=owh

http://nhs4315978.resolver.library.nhs.uk/linker?template=slinks:redirect&linkclass=hlisd&issn=0906-6705&title=Experimental+dermatology&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&provider=customer&pkgName=nhs43159782&jHome=http%3A%2F%2Fwww.hello.nhs.uk%2Fjournal_articles.asp

http://nhs4315978.resolver.library.nhs.uk/linker?template=slinks:redirect&linkclass=hlisd&issn=0906-6705&title=Experimental+dermatology&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&provider=customer&pkgName=nhs43159782&jHome=http%3A%2F%2Fwww.hello.nhs.uk%2Fjournal_articles.asp








http://nhs4315978.resolver.library.nhs.uk/linker?template=slinks:redirect&linkclass=hlisd&issn=0145-2126&title=Leukemia+research&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&provider=customer&pkgName=nhs43159782&jHome=http%3A%2F%2Fwww.hello.nhs.uk%2Fjournal_articles.asp



10

Hofbauer LC

Citation: Spine, 01 August 2009, vol./is. 34/17(0-), 03622436

Publication Date: 01 August 2009

Source: CINAHL


34. Chemotherapy and dasatinib induce long-term hematologic and molecular remission in systemic mastocytosis with acute myeloid leukemia with KIT D816V.

Author(s) Ustun C, Corless CL, Savage N, Fiskus W, Manaloor E, Heinrich MC, Lewis G, Ramalingam P, Kepten I, Jillella A, Bhalla K

Citation: Leukemia Research, May 2009, vol./is. 33/5(735-41), 0145-2126;1873-5835 (2009 May)


Source: Medline


35. Adult onset Urticaria pigmentosa: A case report

Author(s) Prabhu S., Rao R., Sripathi H., Kudva R.

Citation: Journal of Pakistan Association of Dermatologists, April 2009, vol./is. 19/2(115-117), 1560-9014 (April-June 2009)


Source: EMBASE


36. Hereditary cutaneous mastocytosis

Author(s) Fett N., Longley J., Teng J.

Citation: Journal of the American Academy of Dermatology, March 2009, vol./is. 60/3 SUPPL. 1(AB61-AB62), 0190-9622 (March 2009)


Source: EMBASE


37. Lenalidomide therapy in systemic mastocytosis.

Author(s) Kluin-Nelemans HC, Ferenc V, van Doormaal JJ, van Iperen C, Peters WG, Akin C, Valent P

Citation: Leukemia Research, March 2009, vol./is. 33/3(e19-22), 0145-2126;1873-5835 (2009 Mar)


Source: Medline


38. Cutaneous mastocytosis localized to a radiotherapy field.

http://nhs4315978.resolver.library.nhs.uk/linker?template=slinks:redirect&issn=1548-2545&title=Spine&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&provider=customer&pkgName=nhs43159782&jHome=http%3A%2F%2Fgateway.ovid.com%2Fathens%2Fovidweb.cgi%3FT%3DJS%26MODE%3Dovid%26NEWS%3Dn%26PAGE%3Dtoc%26D%3Dovft%26AN%3D00007632-000000000-00000






http://nhs4315978.resolver.library.nhs.uk/linker?template=slinks:redirect&linkclass=hlisd&issn=1560-9014&title=Journal+of+Pakistan+Association+of+Dermatologists&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&provider=customer&pkgName=nhs43159782&jHome=http%3A%2F%2Fwww.hello.nhs.uk%2Fjournal_articles.asp

http://nhs4315978.resolver.library.nhs.uk/linker?template=slinks:redirect&linkclass=hlisd&issn=1560-9014&title=Journal+of+Pakistan+Association+of+Dermatologists&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&provider=customer&pkgName=nhs43159782&jHome=http%3A%2F%2Fwww.hello.nhs.uk%2Fjournal_articles.asp


http://nhs4315978.resolver.library.nhs.uk/linker?linkScheme=harcourt&linktype=best&genre=article&volume=60&issue=3+SUPPL.+1&epage=AB62&issn=0190-9622&date=2009-03&pages=AB61-AB62&aulast=Fett+N&auinit=.&title=Journal+of+the+American+Academy+of+Dermatology&atitle=Hereditary+cutaneous+mastocytosis&sid=Elsevier%3AScienceDirect&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&jHome=http%3A%2F%2Fgateway.ovid.com%2Fathens%2Fovidweb.cgi%3FT%3DJS%26MODE%3Dovid%26NEWS%3Dn%26PAGE%3Dtoc%26D%3Dovft%26AN%3D00004725-000000000-00000&provider=customer&pkgName=nhs43159782





11

Author(s) Soilleux EJ, Brown VL, Bowling J

Citation: Clinical & Experimental Dermatology, January 2009, vol./is. 34/1(111-2), 0307-6938;1365-2230 (2009 Jan)

Publication Date: January 2009

Source: Medline



39. Systemic mastocytosis: classification, pathogenesis, diagnosis, and treatment.

Author(s) Bunimovich O, Grassi M, Baer MR

Citation: Cutis, January 2009, vol./is. 83/1(29-36), 0011-4162;0011-4162 (2009 Jan)


Source: Medline


40. Successful treatment of KIT D816V-positive, imatinib-resistant systemic mastocytosis with interferon-alpha.

Author(s) Yoshida C, Takeuchi M, Tsuchiyama J, Sadahira Y

Citation: Internal Medicine, 2009, vol./is. 48/22(1973-8), 0918-2918;1349-7235 (2009)


Source: Medline


41. Treatment responses to cladribine and dasatinib in rapidly progressing aggressive mastocytosis.

Author(s) Aichberger KJ, Sperr WR, Gleixner KV, Kretschmer A, Valent P

Citation: European Journal of Clinical Investigation, November 2008, vol./is. 38/11(869-73), 0014-2972;1365-2362 (2008 Nov)


Source: Medline



42. Prevention of mast cell activation disorder-associated clinical sequelae of excessive prostaglandin D2 production

Author(s) Butterfield J.H., Weiler C.R.

Citation: International Archives of Allergy and Immunology, November 2008, vol./is. 147/4(338-343), 1018-2438 (November 2008)


Source: EMBASE


http://nhs4315978.resolver.library.nhs.uk/linker?linkScheme=ebscoh&linktype=best&jKey=DF2&dbKey=owh&genre=article&volume=34&issue=1&epage=2&issn=0307-6938&date=2009-01&pages=111-2&aulast=Soilleux&auinit=EJ&title=Clinical+and+Experimental+Dermatology&atitle=Cutaneous+mastocytosis+localized+to+a+radiotherapy+field.&sid=Elsevier%3AScienceDirect&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&jHome=http%3A%2F%2Fsearch.ebscohost.com%2Fdirect.asp%3Fdb%3Dmnh%26jid%3DDF2%26scope%3Dsite&dbKey=owh&provider=EBSCOhost&pkgName=owh




http://nhs4315978.resolver.library.nhs.uk/linker?template=slinks:redirect&linkclass=hlisd&issn=0011-4162&title=Cutis%3B+cutaneous+medicine+for+the+practitioner&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&provider=customer&pkgName=nhs43159782&jHome=http%3A%2F%2Fwww.hello.nhs.uk%2Fjournal_articles.asp

http://nhs4315978.resolver.library.nhs.uk/linker?template=slinks:redirect&linkclass=hlisd&issn=0011-4162&title=Cutis%3B+cutaneous+medicine+for+the+practitioner&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&provider=customer&pkgName=nhs43159782&jHome=http%3A%2F%2Fwww.hello.nhs.uk%2Fjournal_articles.asp







http://nhs4315978.resolver.library.nhs.uk/linker?linkScheme=ebscoh&linktype=best&jKey=EUD&dbKey=owh&genre=article&volume=38&issue=11&epage=73&issn=0014-2972&date=2008-11&pages=869-73&aulast=Aichberger&auinit=KJ&title=European+Journal+of+Clinical+Investigation&atitle=Treatment+responses+to+cladribine+and+dasatinib+in+rapidly+progressing+aggressive+mastocytosis.&sid=Elsevier%3AScienceDirect&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&jHome=http%3A%2F%2Fsearch.ebscohost.com%2Fdirect.asp%3Fdb%3Dmnh%26jid%3DEUD%26scope%3Dsite&dbKey=owh&provider=EBSCOhost&pkgName=owh

http://nhs4315978.resolver.library.nhs.uk/linker?template=slinks:redirect&linkclass=hlisd&issn=0014-2972&title=European+journal+of+clinical+investigation&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&provider=customer&pkgName=nhs43159782&jHome=http%3A%2F%2Fwww.hello.nhs.uk%2Fjournal_articles.asp

http://nhs4315978.resolver.library.nhs.uk/linker?template=slinks:redirect&linkclass=hlisd&issn=0014-2972&title=European+journal+of+clinical+investigation&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&provider=customer&pkgName=nhs43159782&jHome=http%3A%2F%2Fwww.hello.nhs.uk%2Fjournal_articles.asp



http://nhs4315978.resolver.library.nhs.uk/linker?linkScheme=ebscoh&linktype=best&jKey=1GX&dbKey=owh&genre=article&volume=147&issue=4&epage=343&issn=1018-2438&date=2008-11&pages=338-343&aulast=Butterfield+J.H&auinit=.&title=International+Archives+of+Allergy+and+Immunology&atitle=Prevention+of+mast+cell+activation+disorder-associated+clinical+sequelae+of+excessive+prostaglandin+D2+production&sid=Elsevier%3AScienceDirect&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&jHome=http%3A%2F%2Fsearch.ebscohost.com%2Fdirect.asp%3Fdb%3Dmnh%26jid%3D1GX%26scope%3Dsite&dbKey=owh&provider=EBSCOhost&pkgName=owh

12


43. Treatment of chronic autoimmune urticaria with omalizumab

Author(s) Kaplan A.P., Joseph K., Maykut R.J., Geba G.P., Zeldin R.K.

Citation: Journal of Allergy and Clinical Immunology, September 2008, vol./is. 122/3(569-573), 0091-6749 (September 2008)


Source: EMBASE



44. Phase II study of dasatinib in philadelphia chromosome - Negative acute and chronic myeloid diseases, including systemic mastocytosis

Author(s) Verstovsek S., Tefferi A., Cortes J., O'Brien S., Garcia-Manero G., Pardanani A., Akin C., Faderl S., Manshouri T., Thomas D., Kantarjian H.

Citation: Clinical Cancer Research, June 2008, vol./is. 14/12(3906-3915), 1078-0432 (15 Jun 2008)


Source: EMBASE



45. Mast cell leukemia: A report of ten cases

Author(s) Valentini C.G., Rondoni M., Pogliani E.M., Van Lint M.T., Cattaneo C., Marbello L., Pulsoni A., Giona F., Martinelli G., Leone G., Pagano L.

Citation: Annals of Hematology, June 2008, vol./is. 87/6(505-508), 0939-5555 (June 2008)


Source: EMBASE



46. Dasatinib therapy for systemic mastocytosis: Four cases

Author(s) Purtill D., Cooney J., Sinniah R., Carnley B., Cull G., Augustson B., Cannell P.

Citation: European Journal of Haematology, May 2008, vol./is. 80/5(456-458), 0902-4441;1600-0609 (May 2008)


Source: EMBASE






http://nhs4315978.resolver.library.nhs.uk/linker?linkScheme=sciencedirect&linktype=best&genre=article&volume=122&issue=3&epage=573&issn=0091-6749&date=2008-09&pages=569-573&aulast=Kaplan+A.P&auinit=.&title=Journal+of+Allergy+and+Clinical+Immunology&atitle=Treatment+of+chronic+autoimmune+urticaria+with+omalizumab&sid=Elsevier%3AScienceDirect&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&jHome=http%3A%2F%2Fgateway.ovid.com%2Fathens%2Fovidweb.cgi%3FT%3DJS%26MODE%3Dovid%26NEWS%3Dn%26PAGE%3Dtoc%26D%3Dovft%26AN%3D00004483-000000000-00000&provider=customer&pkgName=nhs43159782

http://nhs4315978.resolver.library.nhs.uk/linker?template=slinks:redirect&linkclass=hlisd&issn=0091-6749&title=The+Journal+of+allergy+and+clinical+immunology&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&provider=customer&pkgName=nhs43159782&jHome=http%3A%2F%2Fwww.hello.nhs.uk%2Fjournal_articles.asp




http://nhs4315978.resolver.library.nhs.uk/linker?linkScheme=highwire2&linktype=best&jKey=clincancerres.aacrjournals.org&genre=article&volume=14&issue=12&epage=3915&issn=1078-0432&eissn=1557-3265&date=2008-06&pages=3906-3915&aulast=Verstovsek+S&auinit=.&title=Clinical+Cancer+Research&atitle=Phase+II+study+of+dasatinib+in+philadelphia+chromosome+-+Negative+acute+and+chronic+myeloid+diseases%2C+including+systemic+mastocytosis&sid=Elsevier%3AScienceDirect&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&jHome=http%3A%2F%2Fclincancerres.aacrjournals.org&provider=highwire&pkgName=freeart

http://nhs4315978.resolver.library.nhs.uk/linker?template=slinks:redirect&linkclass=hlisd&issn=1078-0432&title=Clinical+cancer+research+%3A+an+official+journal+of+the+American+Association+for+Cancer+Research&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&provider=customer&pkgName=nhs43159782&jHome=http%3A%2F%2Fwww.hello.nhs.uk%2Fjournal_articles.asp

http://nhs4315978.resolver.library.nhs.uk/linker?template=slinks:redirect&linkclass=hlisd&issn=1078-0432&title=Clinical+cancer+research+%3A+an+official+journal+of+the+American+Association+for+Cancer+Research&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&provider=customer&pkgName=nhs43159782&jHome=http%3A%2F%2Fwww.hello.nhs.uk%2Fjournal_articles.asp


http://nhs4315978.resolver.library.nhs.uk/linker?linkScheme=ebscoh&linktype=best&jKey=1WU&dbKey=owh&genre=article&volume=87&issue=6&epage=508&issn=0939-5555&date=2008-06&pages=505-508&aulast=Valentini+C.G&auinit=.&title=Annals+of+Hematology&atitle=Mast+cell+leukemia%3A+A+report+of+ten+cases&sid=Elsevier%3AScienceDirect&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&jHome=http%3A%2F%2Fsearch.ebscohost.com%2Fdirect.asp%3Fdb%3Dmnh%26jid%3D1WU%26scope%3Dsite&dbKey=owh&provider=EBSCOhost&pkgName=owh

http://nhs4315978.resolver.library.nhs.uk/linker?template=slinks:redirect&linkclass=hlisd&issn=0939-5555&title=Annals+of+hematology&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&provider=customer&pkgName=nhs43159782&jHome=http%3A%2F%2Fwww.hello.nhs.uk%2Fjournal_articles.asp



http://nhs4315978.resolver.library.nhs.uk/linker?linkScheme=ebscoh&linktype=best&jKey=8DW&dbKey=owh&genre=article&volume=80&issue=5&epage=458&issn=0902-4441&date=2008-05&pages=456-458&aulast=Purtill+D&auinit=.&title=European+Journal+of+Haematology&atitle=Dasatinib+therapy+for+systemic+mastocytosis%3A+Four+cases&sid=Elsevier%3AScienceDirect&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&jHome=http%3A%2F%2Fsearch.ebscohost.com%2Fdirect.asp%3Fdb%3Dmnh%26jid%3D8DW%26scope%3Dsite&dbKey=owh&provider=EBSCOhost&pkgName=owh



13

47. High omalizumab dose controls recurrent reactions to venom immunotherapy in indolent systemic mastocytosis.

Author(s) Kontou-Fili K

Citation: Allergy, March 2008, vol./is. 63/3(376-8), 0105-4538;1398-9995 (2008 Mar)


Source: Medline



48. Efficacy of UVA1 phototherapy in 230 patients with various skin diseases.

Author(s) Rombold S, Lobisch K, Katzer K, Grazziotin TC, Ring J, Eberlein B

Citation: Photodermatology, Photoimmunology & Photomedicine, February 2008, vol./is. 24/1(19-23), 0905-4383;0905-4383 (2008 Feb)


Source: Medline



49. Activity of imatinib in systemic mastocytosis with chronic basophilic leukemia and a PRKG2-PDGFRB fusion

Author(s) Lahortiga I., Akin C., Cools J., Wilson T.M., Mentens N., Arthur D.C., Maric I., Noel P., Kocabas C., Marynen P., Lessin L.S., Wlodarska I., Robyn J., Metcalfe D.D.

Citation: Haematologica, January 2008, vol./is. 93/1(49-56), 0390-6078 (January 2008)


Source: EMBASE



50. Treatment of systemic mastocytosis with denileukin diftitox.

Author(s) Quintas-Cardama A, Kantarjian H, Verstovsek S

Citation: American Journal of Hematology, December 2007, vol./is. 82/12(1124), 0361-8609;0361-8609 (2007 Dec)


Source: Medline


51. Treatment of systemic mastocytosis with denileukin diftitox [5]

Author(s) Quintas-Cardama A., Kantarjian H., Verstovsek S.

Citation: American Journal of Hematology, December 2007, vol./is. 82/12(1124), 0361-8609;1096-8652 (December 2007)




http://nhs4315978.resolver.library.nhs.uk/linker?linkScheme=ebscoh&linktype=best&jKey=1X5&dbKey=owh&genre=article&volume=63&issue=3&epage=8&issn=0105-4538&date=2008-03&pages=376-8&aulast=Kontou-Fili&auinit=K&title=Allergy&atitle=High+omalizumab+dose+controls+recurrent+reactions+to+venom+immunotherapy+in+indolent+systemic+mastocytosis.&sid=Elsevier%3AScienceDirect&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&jHome=http%3A%2F%2Fsearch.ebscohost.com%2Fdirect.asp%3Fdb%3Dmnh%26jid%3D1X5%26scope%3Dsite&dbKey=owh&provider=EBSCOhost&pkgName=owh




http://nhs4315978.resolver.library.nhs.uk/linker?linkScheme=ebscoh&linktype=best&jKey=HYQ&dbKey=owh&genre=article&volume=24&issue=1&epage=23&issn=0905-4383&date=2008-02&pages=19-23&aulast=Rombold&auinit=S&title=Photodermatology%2C+Photoimmunology+and+Photomedicine&atitle=Efficacy+of+UVA1+phototherapy+in+230+patients+with+various+skin+diseases.&sid=Elsevier%3AScienceDirect&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&jHome=http%3A%2F%2Fsearch.ebscohost.com%2Fdirect.asp%3Fdb%3Dmnh%26jid%3DHYQ%26scope%3Dsite&dbKey=owh&provider=EBSCOhost&pkgName=owh

http://nhs4315978.resolver.library.nhs.uk/linker?template=slinks:redirect&linkclass=hlisd&issn=0905-4383&title=Photodermatology%2C+photoimmunology+%26+photomedicine&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&provider=customer&pkgName=nhs43159782&jHome=http%3A%2F%2Fwww.hello.nhs.uk%2Fjournal_articles.asp




http://nhs4315978.resolver.library.nhs.uk/linker?template=slinks:redirect&linkclass=hlisd&issn=0390-6078&title=Haematologica&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&provider=customer&pkgName=nhs43159782&jHome=http%3A%2F%2Fwww.hello.nhs.uk%2Fjournal_articles.asp

http://nhs4315978.resolver.library.nhs.uk/linker?template=slinks:redirect&linkclass=hlisd&issn=0390-6078&title=Haematologica&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&provider=customer&pkgName=nhs43159782&jHome=http%3A%2F%2Fwww.hello.nhs.uk%2Fjournal_articles.asp

http://nhs4315978.resolver.library.nhs.uk/linker?linkScheme=highwire2&linktype=best&jKey=www.haematologica.org&genre=article&volume=93&issue=1&epage=56&issn=1592-8721&date=2008-01&pages=49-56&aulast=Lahortiga+I&auinit=.&title=Haematologica&atitle=Activity+of+imatinib+in+systemic+mastocytosis+with+chronic+basophilic+leukemia+and+a+PRKG2-PDGFRB+fusion&sid=Elsevier%3AScienceDirect&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&jHome=http%3A%2F%2Fwww.haematologica.org&provider=highwire&pkgName=freeart





14

Source: EMBASE


52. Systemic Mastocytosis: Documented pathologic response to imatinib

Author(s) Gollard R.P., Ruemmler-Fish C., Garcia D.

Citation: European Journal of Haematology, October 2007, vol./is. 79/4(367-368), 0902-4441;1600-0609 (October 2007)


Source: EMBASE



53. Successful treatment of cutaneous mastocytosis and Meniere disease with anti-IgE therapy.

Author(s) Siebenhaar F, Kuhn W, Zuberbier T, Maurer M

Citation: Journal of Allergy & Clinical Immunology, July 2007, vol./is. 120/1(213-5), 0091-6749;0091-6749 (2007 Jul)


Source: Medline



54. Omalizumab for the treatment of unprovoked anaphylaxis in patients with systemic mastocytosis.

Author(s) Carter MC, Robyn JA, Bressler PB, Walker JC, Shapiro GG, Metcalfe DD

Citation: Journal of Allergy & Clinical Immunology, June 2007, vol./is. 119/6(1550-1), 0091-6749;0091-6749 (2007 Jun)


Source: Medline



55. Juxtamembrane-type c-kit gene mutation found in aggressive systemic mastocytosis induces imatinib-resistant constitutive KIT activation.

Author(s) Nakagomi N, Hirota S

Citation: Laboratory Investigation, April 2007, vol./is. 87/4(365-71), 0023-6837;0023-6837 (2007 Apr)


Source: Medline






http://nhs4315978.resolver.library.nhs.uk/linker?linkScheme=ebscoh&linktype=best&jKey=8DW&dbKey=owh&genre=article&volume=79&issue=4&epage=368&issn=0902-4441&date=2007-10&pages=367-368&aulast=Gollard+R.P&auinit=.&title=European+Journal+of+Haematology&atitle=Systemic+Mastocytosis%3A+Documented+pathologic+response+to+imatinib&sid=Elsevier%3AScienceDirect&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&jHome=http%3A%2F%2Fsearch.ebscohost.com%2Fdirect.asp%3Fdb%3Dmnh%26jid%3D8DW%26scope%3Dsite&dbKey=owh&provider=EBSCOhost&pkgName=owh





http://nhs4315978.resolver.library.nhs.uk/linker?linkScheme=sciencedirect&linktype=best&genre=article&volume=120&issue=1&epage=5&issn=0091-6749&date=2007-07&pages=213-5&aulast=Siebenhaar&auinit=F&title=Journal+of+Allergy+and+Clinical+Immunology&atitle=Successful+treatment+of+cutaneous+mastocytosis+and+Meniere+disease+with+anti-IgE+therapy.&sid=Elsevier%3AScienceDirect&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&jHome=http%3A%2F%2Fgateway.ovid.com%2Fathens%2Fovidweb.cgi%3FT%3DJS%26MODE%3Dovid%26NEWS%3Dn%26PAGE%3Dtoc%26D%3Dovft%26AN%3D00004483-000000000-00000&provider=customer&pkgName=nhs43159782





http://nhs4315978.resolver.library.nhs.uk/linker?linkScheme=sciencedirect&linktype=best&genre=article&volume=119&issue=6&epage=1&issn=0091-6749&date=2007-06&pages=1550-1&aulast=Carter&auinit=MC&title=Journal+of+Allergy+and+Clinical+Immunology&atitle=Omalizumab+for+the+treatment+of+unprovoked+anaphylaxis+in+patients+with+systemic+mastocytosis.&sid=Elsevier%3AScienceDirect&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&jHome=http%3A%2F%2Fgateway.ovid.com%2Fathens%2Fovidweb.cgi%3FT%3DJS%26MODE%3Dovid%26NEWS%3Dn%26PAGE%3Dtoc%26D%3Dovft%26AN%3D00004483-000000000-00000&provider=customer&pkgName=nhs43159782





http://nhs4315978.resolver.library.nhs.uk/linker?linkScheme=ebscoh&linktype=best&jKey=UN9&dbKey=owh&genre=article&volume=87&issue=4&epage=71&issn=0023-6837&date=2007-04&pages=365-71&aulast=Nakagomi&auinit=N&title=Laboratory+Investigation&atitle=Juxtamembrane-type+c-kit+gene+mutation+found+in+aggressive+systemic+mastocytosis+induces+imatinib-resistant+constitutive+KIT+activation.&sid=Elsevier%3AScienceDirect&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&jHome=http%3A%2F%2Fsearch.ebscohost.com%2Fdirect.asp%3Fdb%3Dmnh%26jid%3DUN9%26scope%3Dsite&dbKey=owh&provider=EBSCOhost&pkgName=owh

http://nhs4315978.resolver.library.nhs.uk/linker?template=slinks:redirect&linkclass=hlisd&issn=0023-6837&title=Laboratory+investigation%3B+a+journal+of+technical+methods+and+pathology&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&provider=customer&pkgName=nhs43159782&jHome=http%3A%2F%2Fwww.hello.nhs.uk%2Fjournal_articles.asp

15

articles.

56. Imatinib mesylate responsiveness in aggressive systemic mastocytosis: novel association with a platelet derived growth factor receptor beta mutation.

Author(s) Dalal BI, Horsman DE, Bruyere H, Forrest DL

Citation: American Journal of Hematology, January 2007, vol./is. 82/1(77-9), 0361-8609;0361-8609 (2007 Jan)


Source: Medline


57. Efficacy of 25% diluted fluticasone propionate 0.05% cream as wet-wrap treatment in cutaneous mastocytosis.

Author(s) Heide R, de Waard-van der Spek FB, den Hollander JC, Tank B, Oranje AP

Citation: Dermatology, 2007, vol./is. 214/4(333-5), 1018-8665;1421-9832 (2007)


Source: Medline



58. Imatinib mesylate responsiveness in aggressive systemic mastocytosis: Novel association with a platelet derived growth factor receptor beta mutation

Author(s) Dalal B.I., Horsman D.E., Bruyere H., Forrest D.L.

Citation: American Journal of Hematology, January 2007, vol./is. 82/1(77-79), 0361-8609;1096-8652 (January 2007)


Source: EMBASE


59. UVA1 phototherapy for cutaneous diseases: An experience of 92 cases in the United States

Author(s) Tuchinda C., Kerr H.A., Taylor C.R., Jacobe H., Bergamo B.M., Elmets C., Rivard J., Lim H.W.

Citation: Photodermatology Photoimmunology and Photomedicine, October 2006, vol./is. 22/5(247-253), 0905-4383;1600-0781 (October 2006)


Source: EMBASE



60. Systemic mastocytosis (SM) associated with chronic eosinophilic leukemia (SM-CEL): detection of FIP1L1/PDGFRalpha, classification by WHO criteria, and response

http://nhs4315978.resolver.library.nhs.uk/linker?template=slinks:redirect&linkclass=hlisd&issn=0023-6837&title=Laboratory+investigation%3B+a+journal+of+technical+methods+and+pathology&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&provider=customer&pkgName=nhs43159782&jHome=http%3A%2F%2Fwww.hello.nhs.uk%2Fjournal_articles.asp







http://nhs4315978.resolver.library.nhs.uk/linker?linkScheme=ebscoh&linktype=best&jKey=NIG&dbKey=owh&genre=article&volume=214&issue=4&epage=5&issn=1018-8665&date=2007&pages=333-5&aulast=Heide&auinit=R&title=Dermatology&atitle=Efficacy+of+25%25+diluted+fluticasone+propionate+0.05%25+cream+as+wet-wrap+treatment+in+cutaneous+mastocytosis.&sid=Elsevier%3AScienceDirect&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&jHome=http%3A%2F%2Fsearch.ebscohost.com%2Fdirect.asp%3Fdb%3Dmnh%26jid%3DNIG%26scope%3Dsite&dbKey=owh&provider=EBSCOhost&pkgName=owh

http://nhs4315978.resolver.library.nhs.uk/linker?template=slinks:redirect&linkclass=hlisd&issn=1018-8665&title=Dermatology+%28Basel%2C+Switzerland%29&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&provider=customer&pkgName=nhs43159782&jHome=http%3A%2F%2Fwww.hello.nhs.uk%2Fjournal_articles.asp

http://nhs4315978.resolver.library.nhs.uk/linker?template=slinks:redirect&linkclass=hlisd&issn=1018-8665&title=Dermatology+%28Basel%2C+Switzerland%29&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&provider=customer&pkgName=nhs43159782&jHome=http%3A%2F%2Fwww.hello.nhs.uk%2Fjournal_articles.asp







http://nhs4315978.resolver.library.nhs.uk/linker?linkScheme=ebscoh&linktype=best&jKey=HYQ&dbKey=owh&genre=article&volume=22&issue=5&epage=253&issn=0905-4383&date=2006-10&pages=247-253&aulast=Tuchinda+C&auinit=.&title=Photodermatology%2C+Photoimmunology+and+Photomedicine&atitle=UVA1+phototherapy+for+cutaneous+diseases%3A+An+experience+of+92+cases+in+the+United+States&sid=Elsevier%3AScienceDirect&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&jHome=http%3A%2F%2Fsearch.ebscohost.com%2Fdirect.asp%3Fdb%3Dmnh%26jid%3DHYQ%26scope%3Dsite&dbKey=owh&provider=EBSCOhost&pkgName=owh





16

to therapy with imatinib.

Author(s) Florian S, Esterbauer H, Binder T, Mullauer L, Haas OA, Sperr WR, Sillaber C, Valent P

Citation: Leukemia Research, September 2006, vol./is. 30/9(1201-5), 0145-2126;0145-2126 (2006 Sep)


Source: Medline


61. Treatment of systemic mastocytosis.

Author(s) Wilson TM, Metcalfe DD, Robyn J

Citation: Immunology & Allergy Clinics of North America, 01 August 2006, vol./is. 26/3(549-573), 08898561


Source: CINAHL


62. KIT mutations in mastocytosis and their potential as therapeutic targets.

Author(s) Gotlib J

Citation: Immunology & Allergy Clinics of North America, 01 August 2006, vol./is. 26/3(575-592), 08898561


Source: CINAHL


63. Imatinib mesylate in the treatment of systemic mastocytosis: A phase II trial

Author(s) Droogendijk H.J., Kluin-Nelemans H.J.C., Van Doormaal J.J., Oranje A.P., Van De Loosdrecht A.A., Van Daele P.L.A.

Citation: Cancer, July 2006, vol./is. 107/2(345-351), 0008-543X;1097-0142 (15 Jul 2006)


Source: EMBASE


Available in print at Lincoln County Hospital Professional Library

64. A pilot study of nonmyeloablative allogeneic hematopoietic stem cell transplant for advanced systemic mastocytosis.

Author(s) Nakamura R, Chakrabarti S, Akin C, Robyn J, Bahceci E, Greene A, Childs R, Dunbar CE, Metcalfe DD, Barrett AJ

Citation: Bone Marrow Transplantation, February 2006, vol./is. 37/4(353-8), 0268-3369;0268-3369 (2006 Feb)






http://nhs4315978.resolver.library.nhs.uk/linker?template=slinks:redirect&linkclass=hlisd&issn=0889-8561&title=Immunology+and+allergy+clinics+of+North+America&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&provider=customer&pkgName=nhs43159782&jHome=http%3A%2F%2Fwww.hello.nhs.uk%2Fjournal_articles.asp






http://nhs4315978.resolver.library.nhs.uk/linker?template=slinks:redirect&linkclass=hlisd&issn=0008-543X&title=Cancer&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&provider=customer&pkgName=nhs43159782&jHome=http%3A%2F%2Fwww.hello.nhs.uk%2Fjournal_articles.asp

http://nhs4315978.resolver.library.nhs.uk/linker?template=slinks:redirect&linkclass=hlisd&issn=0008-543X&title=Cancer&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&provider=customer&pkgName=nhs43159782&jHome=http%3A%2F%2Fwww.hello.nhs.uk%2Fjournal_articles.asp



17

Source: Medline



65. First case of an AIDS patient with systemic mast cell disease associated with FIP1-positive eosinophilia treated with imatinib mesylate therapy.

Author(s) Merante S, Chichino G, Boveri E, Gottardi E, Soverini S, Cilloni D, Martinelli G

Citation: Journal of Clinical Oncology, February 2006, vol./is. 24/4(e6-7), 0732-183X;1527-7755 (2006 Feb 1)


Source: Medline


66. PKC412 inhibits in vitro growth of neoplastic human mast cells expressing the D816V-mutated variant of KIT: Comparison with AMN107, imatinib, and cladribine (2CdA) and evaluation of cooperative drug effects

Author(s) Gleixner K.V., Mayerhofer M., Aichberger K.J., Derdak S., Sonneck K., Bohm A., Gruze A., Samorapoompichit P., Manley P.W., Fabbro D., Pickl W.F., Sillaber C., Valent P.

Citation: Blood, January 2006, vol./is. 107/2(752-759), 0006-4971;0006-4971 (15 Jan 2006)


Source: EMBASE



67. Mast cell leukaemia

Author(s) Penack O., Thiel E., Notter M.

Citation: British Journal of Haematology, November 2005, vol./is. 131/4(416), 0007-1048;1365-2141 (November 2005)


Source: EMBASE



68. Cladribine therapy in a patient with an aleukemic subvariant of mast cell leukemia [3]

Author(s) Penack O., Sotlar K., Noack F., Horny H.-P., Thiel E., Notter M.

Citation: Annals of Hematology, October 2005, vol./is. 84/10(692-693), 0939-5555 (October 2005)


Source: EMBASE



http://nhs4315978.resolver.library.nhs.uk/linker?linkScheme=ebscoh&linktype=best&jKey=DZX&dbKey=owh&genre=article&volume=37&issue=4&epage=8&issn=0268-3369&date=2006-02&pages=353-8&aulast=Nakamura&auinit=R&title=Bone+Marrow+Transplantation&atitle=A+pilot+study+of+nonmyeloablative+allogeneic+hematopoietic+stem+cell+transplant+for+advanced+systemic+mastocytosis.&sid=Elsevier%3AScienceDirect&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&jHome=http%3A%2F%2Fsearch.ebscohost.com%2Fdirect.asp%3Fdb%3Dmnh%26jid%3DDZX%26scope%3Dsite&dbKey=owh&provider=EBSCOhost&pkgName=owh

http://nhs4315978.resolver.library.nhs.uk/linker?template=slinks:redirect&linkclass=hlisd&issn=0268-3369&title=Bone+marrow+transplantation&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&provider=customer&pkgName=nhs43159782&jHome=http%3A%2F%2Fwww.hello.nhs.uk%2Fjournal_articles.asp

http://nhs4315978.resolver.library.nhs.uk/linker?template=slinks:redirect&linkclass=hlisd&issn=0268-3369&title=Bone+marrow+transplantation&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&provider=customer&pkgName=nhs43159782&jHome=http%3A%2F%2Fwww.hello.nhs.uk%2Fjournal_articles.asp



http://nhs4315978.resolver.library.nhs.uk/linker?linkScheme=highwire&linktype=best&genre=article&volume=24&issue=4&epage=7&issn=0732-183X&eissn=1527-7755&date=2006-02&pages=e6-7&aulast=Merante&auinit=S&title=Journal+of+Clinical+Oncology&atitle=First+case+of+an+AIDS+patient+with+systemic+mast+cell+disease+associated+with+FIP1-positive+eosinophilia+treated+with+imatinib+mesylate+therapy.&sid=Elsevier%3AScienceDirect&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&jHome=http%3A%2F%2Fwww.jco.org%2Fathens&provider=customer&pkgName=nhs43159782




http://nhs4315978.resolver.library.nhs.uk/linker?linkScheme=highwire2&linktype=best&jKey=bloodjournal.hematologylibrary.org&genre=article&volume=107&issue=2&epage=759&issn=0006-4971&eissn=1528-0020&date=2006-01&pages=752-759&aulast=Gleixner+K.V&auinit=.&title=Blood&atitle=PKC412+inhibits+in+vitro+growth+of+neoplastic+human+mast+cells+expressing+the+D816V-mutated+variant+of+KIT%3A+Comparison+with+AMN107%2C+imatinib%2C+and+cladribine+%282CdA%29+and+evaluation+of+cooperative+drug+effects&sid=Elsevier%3AScienceDirect&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&jHome=http%3A%2F%2Fbloodjournal.hematologylibrary.org&provider=highwire&pkgName=freeart




http://nhs4315978.resolver.library.nhs.uk/linker?linkScheme=ebscoh&linktype=best&jKey=1XW&dbKey=owh&genre=article&volume=131&issue=4&spage=416&issn=0007-1048&date=2005-11&aulast=Penack+O&auinit=.&title=British+Journal+of+Haematology&atitle=Mast+cell+leukaemia&sid=Elsevier%3AScienceDirect&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&jHome=http%3A%2F%2Fsearch.ebscohost.com%2Fdirect.asp%3Fdb%3Dmnh%26jid%3D1XW%26scope%3Dsite&dbKey=owh&provider=EBSCOhost&pkgName=owh

http://nhs4315978.resolver.library.nhs.uk/linker?template=slinks:redirect&linkclass=hlisd&issn=0007-1048&title=British+journal+of+haematology&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&provider=customer&pkgName=nhs43159782&jHome=http%3A%2F%2Fwww.hello.nhs.uk%2Fjournal_articles.asp




http://nhs4315978.resolver.library.nhs.uk/linker?linkScheme=ebscoh&linktype=best&jKey=1WU&dbKey=owh&genre=article&volume=84&issue=10&epage=693&issn=0939-5555&date=2005-10&pages=692-693&aulast=Penack+O&auinit=.&title=Annals+of+Hematology&atitle=Cladribine+therapy+in+a+patient+with+an+aleukemic+subvariant+of+mast+cell+leukemia+%5B3%5D&sid=Elsevier%3AScienceDirect&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&jHome=http%3A%2F%2Fsearch.ebscohost.com%2Fdirect.asp%3Fdb%3Dmnh%26jid%3D1WU%26scope%3Dsite&dbKey=owh&provider=EBSCOhost&pkgName=owh


18

articles.

69. Cladribine therapy in a patient with an aleukemic subvariant of mast cell leukemia.

Author(s) Penack O, Sotlar K, Noack F, Horny HP, Thiel E, Notter M

Citation: Annals of Hematology, October 2005, vol./is. 84/10(692-3), 0939-5555;0939-5555 (2005 Oct)


Source: Medline



70. Systemic mastocytosis: A rare cause of osteoporosis and its response to bisphosphonate treatment

Author(s) Lim A.Y.N., Ostor A.J.K., Love S., Crisp A.J.

Citation: Annals of the Rheumatic Diseases, June 2005, vol./is. 64/6(965-966), 0003-4967 (June 2005)


Source: EMBASE



Available in fulltext at National Library of Medicine


71. Aggressive systemic mastocytosis: a case report and brief review of the literature.

Author(s) Hein MS, Hansen L

Citation: South Dakota Journal of Medicine, March 2005, vol./is. 58/3(95-100), 0038-3317;0038-3317 (2005 Mar)


Source: Medline


72. Successful treatment of systemic mastocytosis with high-dose interferon-alfa: long-term follow-up of a case.

Author(s) Butterfield JH, Tefferi A, Kozuh GF

Citation: Leukemia Research, February 2005, vol./is. 29/2(131-4), 0145-2126;0145-2126 (2005 Feb)


Source: Medline





http://nhs4315978.resolver.library.nhs.uk/linker?linkScheme=ebscoh&linktype=best&jKey=1WU&dbKey=owh&genre=article&volume=84&issue=10&epage=3&issn=0939-5555&date=2005-10&pages=692-3&aulast=Penack&auinit=O&title=Annals+of+Hematology&atitle=Cladribine+therapy+in+a+patient+with+an+aleukemic+subvariant+of+mast+cell+leukemia.&sid=Elsevier%3AScienceDirect&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&jHome=http%3A%2F%2Fsearch.ebscohost.com%2Fdirect.asp%3Fdb%3Dmnh%26jid%3D1WU%26scope%3Dsite&dbKey=owh&provider=EBSCOhost&pkgName=owh





http://nhs4315978.resolver.library.nhs.uk/linker?template=slinks:highwire.stanford.edu/bmj.articleAthens&jKey=ard.bmj.com&genre=article&volume=64&issue=6&epage=966&issn=0003-4967&eissn=1468-2060&date=2005-06&pages=965-966&aulast=Lim+A.Y.N&auinit=.&title=Annals+of+the+Rheumatic+Diseases&atitle=Systemic+mastocytosis%3A+A+rare+cause+of+osteoporosis+and+its+response+to+bisphosphonate+treatment&sid=Elsevier%3AScienceDirect&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&jHome=http%3A%2F%2Fard.bmj.com&dbKey=none%22)&provider=highwire&pkgName=bmj

http://nhs4315978.resolver.library.nhs.uk/linker?linkScheme=highwire2&linktype=best&jKey=ard.bmj.com&genre=article&volume=64&issue=6&epage=966&issn=0003-4967&eissn=1468-2060&date=2005-06&pages=965-966&aulast=Lim+A.Y.N&auinit=.&title=Annals+of+the+Rheumatic+Diseases&atitle=Systemic+mastocytosis%3A+A+rare+cause+of+osteoporosis+and+its+response+to+bisphosphonate+treatment&sid=Elsevier%3AScienceDirect&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&jHome=http%3A%2F%2Fard.bmj.com&provider=highwire&pkgName=freeart

http://nhs4315978.resolver.library.nhs.uk/linker?linkScheme=pubmed&linktype=best&jKey=331&genre=article&volume=64&issue=6&epage=966&issn=0003-4967&eissn=1468-2060&date=2005-06&pages=965-966&aulast=Lim+A.Y.N&auinit=.&title=Annals+of+the+Rheumatic+Diseases&atitle=Systemic+mastocytosis%3A+A+rare+cause+of+osteoporosis+and+its+response+to+bisphosphonate+treatment&sid=Elsevier%3AScienceDirect&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&jHome=http%3A%2F%2Fukpmc.ac.uk%2Fjournals%2F331&provider=NLM&pkgName=UKPMCFT

http://nhs4315978.resolver.library.nhs.uk/linker?template=slinks:redirect&linkclass=hlisd&issn=0003-4967&title=Annals+of+the+rheumatic+diseases&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&provider=customer&pkgName=nhs43159782&jHome=http%3A%2F%2Fwww.hello.nhs.uk%2Fjournal_articles.asp

http://nhs4315978.resolver.library.nhs.uk/linker?template=slinks:redirect&linkclass=hlisd&issn=0003-4967&title=Annals+of+the+rheumatic+diseases&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&provider=customer&pkgName=nhs43159782&jHome=http%3A%2F%2Fwww.hello.nhs.uk%2Fjournal_articles.asp



http://nhs4315978.resolver.library.nhs.uk/linker?template=slinks:redirect&linkclass=hlisd&issn=0038-3317&title=South+Dakota+journal+of+medicine&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&provider=customer&pkgName=nhs43159782&jHome=http%3A%2F%2Fwww.hello.nhs.uk%2Fjournal_articles.asp

http://nhs4315978.resolver.library.nhs.uk/linker?template=slinks:redirect&linkclass=hlisd&issn=0038-3317&title=South+Dakota+journal+of+medicine&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&provider=customer&pkgName=nhs43159782&jHome=http%3A%2F%2Fwww.hello.nhs.uk%2Fjournal_articles.asp





19

73. Management of patients with systemic mastocytosis: review of M. D. Anderson Cancer Center experience.

Author(s) Hennessy B, Giles F, Cortes J, O'brien S, Ferrajoli A, Ossa G, Garcia-Manero G, Faderl S, Kantarjian H, Verstovsek S

Citation: American Journal of Hematology, November 2004, vol./is. 77/3(209-14), 0361-8609;0361-8609 (2004 Nov)


Source: Medline


74. The effect of cutaneous mast cell degranulation on sensitivity to heat.

Author(s) Drummond PD

Citation: Inflammation Research, July 2004, vol./is. 53/7(309-15), 1023-3830;1023-3830 (2004 Jul)


Source: Medline


75. A novel form of mastocytosis associated with a transmembrane c-kit mutation and response to imatinib

Author(s) Akin C., Fumo G., Yavuz A.S., Lipsky P.E., Neckers L., Metcalfe D.D.

Citation: Blood, April 2004, vol./is. 103/8(3222-3225), 0006-4971 (15 Apr 2004)


Source: EMBASE



76. Response to therapy with interferon alpha-2b and prednisolone in aggressive systemic mastocytosis: Report of five cases and review of the literature

Author(s) Hauswirth A.W., Simonitsch-Klupp I., Uffmann M., Koller E., Sperr W.R., Lechner K., Valent P.

Citation: Leukemia Research, March 2004, vol./is. 28/3(249-257), 0145-2126 (March 2004)


Source: EMBASE


77. Leukotriene-receptor inhibition for the treatment of systemic mastocytosis.

Author(s) Tolar J, Tope WD, Neglia JP

Citation: New England Journal of Medicine, 12 February 2004, vol./is. 350/7(735-736), 00284793






http://nhs4315978.resolver.library.nhs.uk/linker?template=slinks:redirect&linkclass=hlisd&issn=1023-3830&title=Inflammation+research+%3A+official+journal+of+the+European+Histamine+Research+Society+...+%5Bet+al.%5D&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&provider=customer&pkgName=nhs43159782&jHome=http%3A%2F%2Fwww.hello.nhs.uk%2Fjournal_articles.asp

http://nhs4315978.resolver.library.nhs.uk/linker?template=slinks:redirect&linkclass=hlisd&issn=1023-3830&title=Inflammation+research+%3A+official+journal+of+the+European+Histamine+Research+Society+...+%5Bet+al.%5D&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&provider=customer&pkgName=nhs43159782&jHome=http%3A%2F%2Fwww.hello.nhs.uk%2Fjournal_articles.asp



http://nhs4315978.resolver.library.nhs.uk/linker?linkScheme=highwire2&linktype=best&jKey=bloodjournal.hematologylibrary.org&genre=article&volume=103&issue=8&epage=3225&issn=0006-4971&eissn=1528-0020&date=2004-04&pages=3222-3225&aulast=Akin+C&auinit=.&title=Blood&atitle=A+novel+form+of+mastocytosis+associated+with+a+transmembrane+c-kit+mutation+and+response+to+imatinib&sid=Elsevier%3AScienceDirect&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&jHome=http%3A%2F%2Fbloodjournal.hematologylibrary.org&provider=highwire&pkgName=freeart








20

Publication Date: 12 February 2004

Source: CINAHL


Available in print at Grantham Hospital Staff Library


Available in print at Louth County Hospital Medical Library

Available in print at Pilgrim Hospital Staff Library


78. Treatment of systemic mast cell disease with 2-chlorodeoxyadenosine

Author(s) Pardanani A., Hoffbrand A.V., Butterfield J.H., Tefferi A.

Citation: Leukemia Research, February 2004, vol./is. 28/2(127-131), 0145-2126 (February 2004)


Source: EMBASE


79. Clinical, genetic, and therapeutic insights into systemic mast cell disease.

Author(s) Tefferi A, Pardanani A

Citation: Current Opinion in Hematology, January 2004, vol./is. 11/1(58-64), 1065-6251;1065-6251 (2004 Jan)


Source: Medline

Available in fulltext at Ovid


80. Cladribine therapy for systemic mastocytosis.

Author(s) Kluin-Nelemans HC, Oldhoff JM, Van Doormaal JJ, Van 't Wout JW, Verhoef G, Gerrits WB, van Dobbenburgh OA, Pasmans SG, Fijnheer R

Citation: Blood, December 2003, vol./is. 102/13(4270-6), 0006-4971;0006-4971 (2003 Dec 15)


Source: Medline



81. CHIC2 deletion, a surrogate for FIP1L1-PDGFRA fusion, occurs in systemic mastocytosis associated with eosinophilia and predicts response to imatinib mesylate therapy.

Author(s) Pardanani A, Ketterling RP, Brockman SR, Flynn HC, Paternoster SF, Shearer BM, Reeder TL, Li CY, Cross NC, Cools J, Gilliland DG, Dewald GW, Tefferi A

Citation: Blood, November 2003, vol./is. 102/9(3093-6), 0006-4971;0006-4971 (2003 Nov

http://nhs4315978.resolver.library.nhs.uk/linker?linkScheme=ebscoh&linktype=best&jKey=NEJ&dbKey=owh&genre=article&volume=350&issue=7&epage=2&issn=0028-4793&date=2004-02-04&pages=735-2&aulast=Tolar&auinit=J&title=New+England+Journal+of+Medicine&atitle=Leukotriene-receptor+inhibition+for+the+treatment+of+systemic+mastocytosis.&sid=Elsevier%3AScienceDirect&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&jHome=http%3A%2F%2Fsearch.ebscohost.com%2Fdirect.asp%3Fdb%3Dmnh%26jid%3DNEJ%26scope%3Dsite&dbKey=owh&provider=EBSCOhost&pkgName=owh

http://nhs4315978.resolver.library.nhs.uk/linker?linkScheme=nejm&linktype=best&genre=article&volume=350&issue=7&epage=2&issn=0028-4793&eissn=1533-4406&date=2004-02-04&pages=735-2&aulast=Tolar&auinit=J&title=New+England+Journal+of+Medicine&atitle=Leukotriene-receptor+inhibition+for+the+treatment+of+systemic+mastocytosis.&sid=Elsevier%3AScienceDirect&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&jHome=http%3A%2F%2Fcontent.nejm.org%2Fathens&provider=customer&pkgName=nhs43159782





http://nhs4315978.resolver.library.nhs.uk/linker?linkScheme=ovid&linktype=best&jKey=00062752-000000000-00000&dbKey=OVFT&genre=article&volume=11&issue=1&epage=64&issn=1065-6251&date=2004-01&pages=58-64&aulast=Tefferi&auinit=A&title=Current+Opinion+in+Hematology&atitle=Clinical%2C+genetic%2C+and+therapeutic+insights+into+systemic+mast+cell+disease.&sid=Elsevier%3AScienceDirect&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&jHome=http%3A%2F%2Fovidsp.ovid.com%2Fathens%2Fovidweb.cgi%3FT%3DJS%26NEWS%3Dn%26CSC%3DY%26PAGE%3Dtoc%26D%3Dovft%26AN%3D00062752-000000000-00000&provider=Ovid&pkgName=journalsAthens




http://nhs4315978.resolver.library.nhs.uk/linker?linkScheme=highwire2&linktype=best&jKey=bloodjournal.hematologylibrary.org&genre=article&volume=102&issue=13&epage=6&issn=0006-4971&eissn=1528-0020&date=2003-12&pages=4270-6&aulast=Kluin-Nelemans&auinit=HC&title=Blood&atitle=Cladribine+therapy+for+systemic+mastocytosis.&sid=Elsevier%3AScienceDirect&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&jHome=http%3A%2F%2Fbloodjournal.hematologylibrary.org&provider=highwire&pkgName=freeart






21

1)


Source: Medline



82. Medium- versus high-dose ultraviolet A1 therapy for urticaria pigmentosa: a pilot study.

Author(s) Gobello T, Mazzanti C, Sordi D, Annessi G, Abeni D, Chinni LM, Girolomoni G

Citation: Journal of the American Academy of Dermatology, October 2003, vol./is. 49/4(679-84), 0190-9622;0190-9622 (2003 Oct)


Source: Medline



83. Imatinib for systemic mast-cell disease.

Author(s) Pardanani A, Elliott M, Reeder T, Li CY, Baxter EJ, Cross NC, Tefferi A

Citation: Lancet, August 2003, vol./is. 362/9383(535-6), 0140-6736;1474-547X (2003 Aug 16)


Source: Medline





Available in print at Louth County Hospital Medical Library



84. Aggressive systemic mastocytosis

Author(s) Inaoui R., Petit B., Jaccard A., Bertin P., Treves R.

Citation: Joint Bone Spine, February 2003, vol./is. 70/1(64-66), 1297-319X (February 2003)


Source: EMBASE

85. Treatment of adult systemic mastocytosis with interferon-alpha: results of a multicentre phase II trial on 20 patients.

Author(s) Casassus P, Caillat-Vigneron N, Martin A, Simon J, Gallais V, Beaudry P, Eclache V, Laroche L, Lortholary P, Raphael M, Guillevin L, Lortholary O

Citation: British Journal of Haematology, December 2002, vol./is. 119/4(1090-7), 0007-

http://nhs4315978.resolver.library.nhs.uk/linker?linkScheme=highwire2&linktype=best&jKey=bloodjournal.hematologylibrary.org&genre=article&volume=102&issue=9&epage=6&issn=0006-4971&eissn=1528-0020&date=2003-11&pages=3093-6&aulast=Pardanani&auinit=A&title=Blood&atitle=CHIC2+deletion%2C+a+surrogate+for+FIP1L1-PDGFRA+fusion%2C+occurs+in+systemic+mastocytosis+associated+with+eosinophilia+and+predicts+response+to+imatinib+mesylate+therapy.&sid=Elsevier%3AScienceDirect&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&jHome=http%3A%2F%2Fbloodjournal.hematologylibrary.org&provider=highwire&pkgName=freeart





http://nhs4315978.resolver.library.nhs.uk/linker?linkScheme=harcourt&linktype=best&genre=article&volume=49&issue=4&epage=84&issn=0190-9622&date=2003-10&pages=679-84&aulast=Gobello&auinit=T&title=Journal+of+the+American+Academy+of+Dermatology&atitle=Medium-+versus+high-dose+ultraviolet+A1+therapy+for+urticaria+pigmentosa%3A+a+pilot+study.&sid=Elsevier%3AScienceDirect&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&jHome=http%3A%2F%2Fgateway.ovid.com%2Fathens%2Fovidweb.cgi%3FT%3DJS%26MODE%3Dovid%26NEWS%3Dn%26PAGE%3Dtoc%26D%3Dovft%26AN%3D00004725-000000000-00000&provider=customer&pkgName=nhs43159782


http://nhs4315978.resolver.library.nhs.uk/linker?template=slinks:redirect&linkclass=hlisd&issn=0140-6736&title=The+Lancet&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&provider=customer&pkgName=nhs43159782&jHome=http%3A%2F%2Fwww.hello.nhs.uk%2Fjournal_articles.asp

http://nhs4315978.resolver.library.nhs.uk/linker?template=slinks:redirect&linkclass=hlisd&issn=0140-6736&title=The+Lancet&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&provider=customer&pkgName=nhs43159782&jHome=http%3A%2F%2Fwww.hello.nhs.uk%2Fjournal_articles.asp

http://nhs4315978.resolver.library.nhs.uk/linker?linkScheme=ebscoh&linktype=best&jKey=LAN&dbKey=owh&genre=article&volume=362&issue=9383&epage=6&issn=0099-5355&date=2003-08&pages=535-6&aulast=Pardanani&auinit=A&title=Lancet&atitle=Imatinib+for+systemic+mast-cell+disease.&sid=Elsevier%3AScienceDirect&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&jHome=http%3A%2F%2Fsearch.ebscohost.com%2Fdirect.asp%3Fdb%3Dmnh%26jid%3DLAN%26scope%3Dsite&dbKey=owh&provider=EBSCOhost&pkgName=owh

http://nhs4315978.resolver.library.nhs.uk/linker?template=slinks:redirect&linkclass=hlisd&issn=0140-6736&title=Lancet&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&provider=customer&pkgName=nhs43159782&jHome=http%3A%2F%2Fwww.hello.nhs.uk%2Fjournal_articles.asp

http://nhs4315978.resolver.library.nhs.uk/linker?template=slinks:redirect&linkclass=hlisd&issn=0140-6736&title=Lancet&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&provider=customer&pkgName=nhs43159782&jHome=http%3A%2F%2Fwww.hello.nhs.uk%2Fjournal_articles.asp




22

1048;0007-1048 (2002 Dec)


Source: Medline



86. Treatment of systemic mast-cell disease with cladribine [3]

Author(s) Tefferi A., Li C.-Y., Butterfield J.H., Hoagland H.C.

Citation: New England Journal of Medicine, January 2001, vol./is. 344/4(307-309), 0028-4793 (25 Jan 2001)


Source: EMBASE





87. Effects of interferon-alpha2b treatment on ex vivo differentiation of mast cells from circulating progenitor cells in a patient with systemic mastocytosis.

Author(s) Schernthaner GH, Spanblochl E, Sperr WR, Sillaber C, Semper H, Jurecka W, Hagen W, Wolff K, Chott A, Lechner K, Valent P

Citation: Annals of Hematology, December 2000, vol./is. 79/12(660-6), 0939-5555;0939-5555 (2000 Dec)


Source: Medline



88. The treatment of urticaria pigmentosa with the frequency-doubled Q-switch Nd:YAG laser.

Author(s) Bedlow AJ, Gharrie S, Harland CC

Citation: Journal of Cutaneous Laser Therapy, March 2000, vol./is. 2/1(45-7), 1462-883X;1462-883X (2000 Mar)


Source: Medline



Google Scholar

From 1st 50 results…

Diagnosis and treatment of systemic mastocytosis: state of the art

http://nhs4315978.resolver.library.nhs.uk/linker?linkScheme=ebscoh&linktype=best&jKey=1XW&dbKey=owh&genre=article&volume=119&issue=4&epage=7&issn=0007-1048&date=2002-12&pages=1090-7&aulast=Casassus&auinit=P&title=British+Journal+of+Haematology&atitle=Treatment+of+adult+systemic+mastocytosis+with+interferon-alpha%3A+results+of+a+multicentre+phase+II+trial+on+20+patients.&sid=Elsevier%3AScienceDirect&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&jHome=http%3A%2F%2Fsearch.ebscohost.com%2Fdirect.asp%3Fdb%3Dmnh%26jid%3D1XW%26scope%3Dsite&dbKey=owh&provider=EBSCOhost&pkgName=owh




http://nhs4315978.resolver.library.nhs.uk/linker?linkScheme=ebscoh&linktype=best&jKey=NEJ&dbKey=owh&genre=article&volume=344&issue=4&epage=309&issn=0028-4793&date=2001-01&pages=307-309&aulast=Tefferi+A&auinit=.&title=New+England+Journal+of+Medicine&atitle=Treatment+of+systemic+mast-cell+disease+with+cladribine+%5B3%5D&sid=Elsevier%3AScienceDirect&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&jHome=http%3A%2F%2Fsearch.ebscohost.com%2Fdirect.asp%3Fdb%3Dmnh%26jid%3DNEJ%26scope%3Dsite&dbKey=owh&provider=EBSCOhost&pkgName=owh

http://nhs4315978.resolver.library.nhs.uk/linker?linkScheme=nejm&linktype=best&genre=article&volume=344&issue=4&epage=309&issn=0028-4793&eissn=1533-4406&date=2001-01&pages=307-309&aulast=Tefferi+A&auinit=.&title=New+England+Journal+of+Medicine&atitle=Treatment+of+systemic+mast-cell+disease+with+cladribine+%5B3%5D&sid=Elsevier%3AScienceDirect&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&jHome=http%3A%2F%2Fcontent.nejm.org%2Fathens&provider=customer&pkgName=nhs43159782



http://nhs4315978.resolver.library.nhs.uk/linker?linkScheme=ebscoh&linktype=best&jKey=1WU&dbKey=owh&genre=article&volume=79&issue=12&epage=6&issn=0939-5555&date=2000-12&pages=660-6&aulast=Schernthaner&auinit=GH&title=Annals+of+Hematology&atitle=Effects+of+interferon-alpha2b+treatment+on+ex+vivo+differentiation+of+mast+cells+from+circulating+progenitor+cells+in+a+patient+with+systemic+mastocytosis.&sid=Elsevier%3AScienceDirect&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&jHome=http%3A%2F%2Fsearch.ebscohost.com%2Fdirect.asp%3Fdb%3Dmnh%26jid%3D1WU%26scope%3Dsite&dbKey=owh&provider=EBSCOhost&pkgName=owh





http://nhs4315978.resolver.library.nhs.uk/linker?linkScheme=ebscoh&linktype=best&jKey=B9K&dbKey=owh&genre=article&volume=2&issue=1&epage=7&issn=1462-883X&date=2000-03&pages=45-7&aulast=Bedlow&auinit=AJ&title=Journal+of+Cutaneous+Laser+Therapy&atitle=The+treatment+of+urticaria+pigmentosa+with+the+frequency-doubled+Q-switch+Nd%3AYAG+laser.&sid=Elsevier%3AScienceDirect&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&jHome=http%3A%2F%2Fsearch.ebscohost.com%2Fdirect.asp%3Fdb%3Dmnh%26jid%3DB9K%26scope%3Dsite&dbKey=owh&provider=EBSCOhost&pkgName=owh

http://nhs4315978.resolver.library.nhs.uk/linker?template=slinks:redirect&linkclass=hlisd&issn=1462-883X&title=Journal+of+cutaneous+laser+therapy&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&provider=customer&pkgName=nhs43159782&jHome=http%3A%2F%2Fwww.hello.nhs.uk%2Fjournal_articles.asp

http://nhs4315978.resolver.library.nhs.uk/linker?template=slinks:redirect&linkclass=hlisd&issn=1462-883X&title=Journal+of+cutaneous+laser+therapy&rfr_id=info%3Asid%2Felsevier.com%3AScienceDirect&provider=customer&pkgName=nhs43159782&jHome=http%3A%2F%2Fwww.hello.nhs.uk%2Fjournal_articles.asp

http://onlinelibrary.wiley.com/doi/10.1046/j.1365-2141.2003.04575.x/full

23

P Valent, C Akin, WR Sperr… - British journal of …, 2003 - Wiley Online Library Mast cells are tissue-fixed cells originating from uncommitted and mast cell-committed haematopoietic progenitors (Kitamura et al, 1981; Kirshenbaum et al, 1992; Agis et al, 1993; Rottem et al, 1994; Kempuraj et al, 1999). Mast cell-committed progenitors co-express ... Cited by 131 - Related articles - Find@The Christie - BL Direct - All 7 versions

Aggressive systemic mastocytosis and related mast cell disorders: current treatment options and proposed response criteria

P Valent, C Akin, WR Sperr, L Escribano… - Leukemia research, 2003 - Elsevier Aggressive systemic mastocytosis (ASM) is a clonal mast cell disease characterized by progressive growth of neoplastic cells in diverse organs leading to organopathy. The organ systems most frequently affected are the bone marrow, skeletal system, liver, spleen, and ... Cited by 92 - Related articles - All 10 versions

Systemic mastocytosis: current concepts and treatment advances.

A Tefferi… - Current hematology reports, 2004 - ncbi.nlm.nih.gov Systemic mastocytosis (SM), as opposed to cutaneous-only mastocytosis, implies the presence of neoplastic mast cell infiltration in extracutaneous tissue. Mast cell disease in adults is often systemic and often involves the bone marrow. Typical clinical and ... Cited by 35 - Related articles- Lancashire Teaching Hospitals- Find@The Christie - BL Direct

Novel approaches in the treatment of systemic mastocytosis

A Quintas‐Cardama, A Aribi, J Cortes, FJ Giles… - Cancer, 2006 - Wiley Online Library In the absence of curative options, therapy for aggressive forms of systemic mastocytosis (SM) has relied in the use of cytoreductive agents, mainly interferon-α (IFN-α) and cladribine. However, responses are transient and only occur in a subset of patients. Gain-of-function ... Cited by 42 - Related articles- Find@The Christie - BL Direct - All 3 versions

Interferon treatment for hypereosinophilic syndromes and systemic mastocytosis

JH Butterfield - Acta haematologica, 2005 - content.karger.com Hypereosinophilic syndromes (HES) and systemic mastocytosis (SMCD) are heterogeneous disorders with clinical symptoms from local and remote effects of excessive proliferation of eosinophils and mast cells, respec tively. Interferon α (IFN-α), alone or in combination with ... Cited by 44 - Related articles- The Christie Online Journals - BL Direct - All 6 versions

Mastocytosis: current concepts in diagnosis and treatment

L Escribano, C Akin, M Castells, A Orfao… - Annals of hematology, 2002 - Springer ... cutaneous disease, but only in symptomatic cases Diffuse cutaneous mastocytosis € bullae Avoidance ... match is available Consider splenectomy Smoldering systemic mastocytosis Consider interferon ... Rapidly progressive aggressive mastocytosis or mast cell leukemia Watch for ... Cited by 110 - Related articles - Find@The Christie - BL Direct - All 5 versions

Treatment of systemic mast cell disorders

AS Worobec - Hematology/oncology clinics of North America, 2000 - Elsevier ... Treatment of refractory hypotension and shock requires fluid resuscitative measures and additional pharmacologic intervention. ... 1:10,000 epinephrine infusion (up to 4–10 μg/min in adults and 0.1μg/kg/min in children) is generally recommended as first-line therapy. ... Cited by 94 - Related articles - BL Direct - All 5 versions

Treatment of cutaneous mastocytosis

K Wolff - International archives of allergy and immunology, 2002 - content.karger.com ... Smith ML, Orton PW, Chu H, Weston WL: Photochemotherapy of dominant, diffuse cutaneous mastocytosis. ... Godt O, Proksch E, Streit V, Christophers E: Short- and long-term effectiveness of oral and bath PUVA therapy in urticaria pigmentosa and systemic mastocytosis. ... Cited by 34 - Related articles - BL Direct - All 4 versions

http://scholar.google.co.uk/scholar?cites=10161632620454416633&as_sdt=2005&sciodt=1,5&hl=en

http://scholar.google.co.uk/scholar?q=related:-RA1mAdfBY0J:scholar.google.com/&hl=en&as_sdt=1,5&as_ylo=2000&as_yhi=2012&as_vis=1

http://scholar.google.co.uk/scholar?q=info:-RA1mAdfBY0J:scholar.google.com/&output=instlink&hl=en&as_sdt=1,5&as_ylo=2000&as_yhi=2012&as_vis=1&scillfp=1264620302014297602

http://direct.bl.uk/research/46/10/RN136493993.html?source=googlescholar

http://scholar.google.co.uk/scholar?cluster=10161632620454416633&hl=en&as_sdt=1,5&as_ylo=2000&as_yhi=2012&as_vis=1

http://www.sciencedirect.com/science/article/pii/S0145212602001686



http://scholar.google.co.uk/scholar?q=related:yGArtDZ31zsJ:scholar.google.com/&hl=en&as_sdt=1,5&as_ylo=2000&as_yhi=2012&as_vis=1


http://www.ncbi.nlm.nih.gov/pubmed/15087068


http://scholar.google.co.uk/scholar?q=related:1d_2ijY6WyYJ:scholar.google.com/&hl=en&as_sdt=1,5&as_ylo=2000&as_yhi=2012&as_vis=1

http://scholar.google.co.uk/scholar?q=info:1d_2ijY6WyYJ:scholar.google.com/&output=instlink&hl=en&as_sdt=1,5&as_ylo=2000&as_yhi=2012&as_vis=1&scillfp=5710020028774977663

http://scholar.google.co.uk/scholar?q=info:1d_2ijY6WyYJ:scholar.google.com/&output=instlink&hl=en&as_sdt=1,5&as_ylo=2000&as_yhi=2012&as_vis=1&scillfp=5795708541477387150



http://onlinelibrary.wiley.com/doi/10.1002/cncr.22187/full


http://scholar.google.co.uk/scholar?q=related:avKCQ7gL_BQJ:scholar.google.com/&hl=en&as_sdt=1,5&as_ylo=2000&as_yhi=2012&as_vis=1

http://scholar.google.co.uk/scholar?q=info:avKCQ7gL_BQJ:scholar.google.com/&output=instlink&hl=en&as_sdt=1,5&as_ylo=2000&as_yhi=2012&as_vis=1&scillfp=8028598341949229472



http://content.karger.com/ProdukteDB/produkte.asp?Aktion=ShowAbstract&ProduktNr=223829&Ausgabe=230919&ArtikelNr=85560


http://scholar.google.co.uk/scholar?q=related:xDnRPM1JQloJ:scholar.google.com/&hl=en&as_sdt=1,5&as_ylo=2000&as_yhi=2012&as_vis=1

http://scholar.google.co.uk/scholar?q=info:xDnRPM1JQloJ:scholar.google.com/&output=instlink&hl=en&as_sdt=1,5&as_ylo=2000&as_yhi=2012&as_vis=1&scillfp=6150357132685240918

http://direct.bl.uk/research/1F/13/RN171151180.html?source=googlescholar


http://www.springerlink.com/index/BWR8L3X4X75JEGQQ.pdf


http://scholar.google.co.uk/scholar?q=related:-1VJc8TMnygJ:scholar.google.com/&hl=en&as_sdt=1,5&as_ylo=2000&as_yhi=2012&as_vis=1

http://scholar.google.co.uk/scholar?q=info:-1VJc8TMnygJ:scholar.google.com/&output=instlink&hl=en&as_sdt=1,5&as_ylo=2000&as_yhi=2012&as_vis=1&scillfp=5502139994394302025

http://direct.bl.uk/research/05/3E/RN124259812.html?source=googlescholar




http://scholar.google.co.uk/scholar?q=related:Uz4rrXwpeSUJ:scholar.google.com/&hl=en&as_sdt=1,5&as_ylo=2000&as_yhi=2012&as_vis=1

http://direct.bl.uk/research/1E/58/RN081665280.html?source=googlescholar




http://scholar.google.co.uk/scholar?q=related:frjGjTT5xWsJ:scholar.google.com/&hl=en&as_sdt=1,5&as_ylo=2000&as_yhi=2012&as_vis=1

http://direct.bl.uk/research/5A/15/RN111448668.html?source=googlescholar


24

Imatinib therapy in clonal eosinophilic disorders, including systemic mastocytosis

A Tefferi… - International journal of hematology, 2004 - Springer Abstract Primary (nonreactive) eosinophilia is operationally classified as either a “clonal” or an “idiopathic” process. Clonal eosinophilia stipulates the presence of cytogenetic, molecular, or bone marrow histologic evidence of acute leukemia or a chronic myeloid ... Cited by 23 - Related articles- Lancashire Teaching Hospitals- Find@The Christie - BL Direct - All 6 versions

Pathogenesis, clinical features, and treatment advances in mastocytosis

A Pardanani, C Akin… - Best Practice & Research Clinical …, 2006 - Elsevier ... been identified in systemic mastocytosis as well as in mast cell leukemia (MCL). ... Eosinophilia commonly accompanies systemic mastocytosis (in 20–40% of cases) [78] , [79] , [80 ... common is urticaria pigmentosa (UP); the others being diffuse cutaneous mastocytosis (DCM) and ... Cited by 57 - Related articles- Lancashire Teaching Hospitals- Find@The Christie - All 7 versions

Treatment of systemic mastocytosis.

TM Wilson, DD Metcalfe, J Robyn - Immunology and allergy clinics …, 2006 - ukpmc.ac.uk It is an exciting time in the treatment of systemic mastocytosis. Major advances in the past 2 decades have helped to define the molecular abnormalities associated with this disease and to delineate pathways involved in its pathogenesis. This has directly translated into ... Cited by 14 - Related articles - Cached- Lancashire Teaching Hospitals- Find@The Christie - All 5 versions

Mastocytosis: current treatment concepts

AS Worobec… - International archives of allergy …, 2002 - content.karger.com ... beneficial in addition to antihistamines [2, 3, 4]. Urticaria pigmentosa (UP) and diffuse cutaneous mastocytosis (DCM) have ... mastocytosis with an associated clonal hematologic non-mast cell lineage disease, aggressive systemic mastocytosis and mast cell leukemia are at ... Cited by 27 - Related articles - BL Direct - All 4 versions

Mastocytosis: pathology, genetics, and current options for therapy

P Valent, C Akin, W Sperr… - Leukemia & …, 2005 - informahealthcare.com ... (ii) diffuse cutaneous mastocytosis (DCM); and (iii) mastocytoma of the skin [51,69,70]. ... SM-MPD – SM-HES – SM-CMML – SM-NHL Aggressive systemic mastocytosis ASM – Lymphadenopathic SM with eosinophilia Mast cell leukemia MCL – Aleukemic MCL ... Cited by 140 - Related articles- Lancashire Teaching Hospitals- Find@The Christie - All 9 versions

http://www.springerlink.com/index/K1TU0HGXMTRJW2D6.pdf


http://scholar.google.co.uk/scholar?q=related:rNrc0La7aIQJ:scholar.google.com/&hl=en&as_sdt=1,5&as_ylo=2000&as_yhi=2012&as_vis=1

http://scholar.google.co.uk/scholar?q=info:rNrc0La7aIQJ:scholar.google.com/&output=instlink&hl=en&as_sdt=1,5&as_ylo=2000&as_yhi=2012&as_vis=1&scillfp=5903356019272951627

http://scholar.google.co.uk/scholar?q=info:rNrc0La7aIQJ:scholar.google.com/&output=instlink&hl=en&as_sdt=1,5&as_ylo=2000&as_yhi=2012&as_vis=1&scillfp=7609546027531570936






http://scholar.google.co.uk/scholar?q=related:tRBGD7uYpHMJ:scholar.google.com/&hl=en&as_sdt=1,5&as_ylo=2000&as_yhi=2012&as_vis=1

http://scholar.google.co.uk/scholar?q=info:tRBGD7uYpHMJ:scholar.google.com/&output=instlink&hl=en&as_sdt=1,5&as_ylo=2000&as_yhi=2012&as_vis=1&scillfp=8728098130918556309

http://scholar.google.co.uk/scholar?q=info:tRBGD7uYpHMJ:scholar.google.com/&output=instlink&hl=en&as_sdt=1,5&as_ylo=2000&as_yhi=2012&as_vis=1&scillfp=6084367880619744656



http://ukpmc.ac.uk/abstract/MED/16931293


http://scholar.google.co.uk/scholar?q=related:7tGDfQeMCyIJ:scholar.google.com/&hl=en&as_sdt=1,5&as_ylo=2000&as_yhi=2012&as_vis=1

http://scholar.googleusercontent.com/scholar?q=cache:7tGDfQeMCyIJ:scholar.google.com/+(~%22diffuse+cutaneous+mastocytosis%22+OR+~%22diffuse+mastocytosis%22+OR+~%22systemic+mastocytosis%22+OR+~%22mast-cell+leukemia%22+OR+~%22urticartia+pigmentosa%22)+(~therapy+OR+~treatment+OR+~intervention+OR+~management)&hl=en&as_sdt=1,5&as_ylo=2000&as_yhi=2012&as_vis=1

http://scholar.google.co.uk/scholar?q=info:7tGDfQeMCyIJ:scholar.google.com/&output=instlink&hl=en&as_sdt=1,5&as_ylo=2000&as_yhi=2012&as_vis=1&scillfp=16646587654072782760

http://scholar.google.co.uk/scholar?q=info:7tGDfQeMCyIJ:scholar.google.com/&output=instlink&hl=en&as_sdt=1,5&as_ylo=2000&as_yhi=2012&as_vis=1&scillfp=4742067073335038862




http://scholar.google.co.uk/scholar?q=related:96AnHyvFjBIJ:scholar.google.com/&hl=en&as_sdt=1,5&as_ylo=2000&as_yhi=2012&as_vis=1

http://direct.bl.uk/research/1F/61/RN111448656.html?source=googlescholar


http://informahealthcare.com/doi/abs/10.1080/10428190400010775


http://scholar.google.co.uk/scholar?q=related:R-Ym6YuiKtIJ:scholar.google.com/&hl=en&as_sdt=1,5&as_ylo=2000&as_yhi=2012&as_vis=1

http://scholar.google.co.uk/scholar?q=info:R-Ym6YuiKtIJ:scholar.google.com/&output=instlink&hl=en&as_sdt=1,5&as_ylo=2000&as_yhi=2012&as_vis=1&scillfp=5121742157805071983

http://scholar.google.co.uk/scholar?q=info:R-Ym6YuiKtIJ:scholar.google.com/&output=instlink&hl=en&as_sdt=1,5&as_ylo=2000&as_yhi=2012&as_vis=1&scillfp=4560361808955024750



Documents

Library and Knowledge Services - HeLLO of... · Library and Knowledge Services . ... light eruption,20 prurigo simplex subacuta,21 ... Another trial is looking at a tyrosine kinase